≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Dermatophytosis

EFO Endpoint Browser PheWeb

AB1_DERMATOPHYTOSIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B35
  • Hospital discharge: ICD-9 — 110
  • Hospital discharge: ICD-8 — 110
  • Cause of death: ICD-10 — B35
  • Cause of death: ICD-9 — 110
  • Cause of death: ICD-8 — 110

2 out of 7 registries used, show all original rules.

5219

4. Check minimum number of events

None

5219

5. Include endpoints

None

5219

6. Filter based on genotype QC (FinnGen only)

5219

Control definitions (FinnGen only)

Control exclude
AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 36369 15440 20714
Only index persons 32219 13723 18496
Unadjusted period prevalence (%)
Whole population 0.52 0.44 0.58
Only index persons 0.62 0.50 0.71
Median age at first event (years)
Whole population 54.08 55.94 52.65
Only index persons 53.56 55.39 52.20

-FinnGen-

Key figures

All Female Male
Number of individuals 5219 2228 2991
Unadjusted period prevalence (%) 1.08 0.76 1.32
Median age at first event (years) 57.42 55.45 58.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4649
Matched controls
46487
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B35.3
ICD-10 Finland
Tinea pedis
50.3
323.0
1819
586
B35.1
ICD-10 Finland
Tinea unguium
29.1
323.0
1865
1045
D01BA02
ATC
terbinafine; oral; topical
5.6
323.0
2451
7728
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
19.7
309.2
481
271
D01AE16
ATC
amorolfine; topical
4.6
275.6
1097
2900
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.8
266.4
1367
4559
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
3.4
257.5
1655
6573
B35.4
ICD-10 Finland
Tinea corporis
28.4
240.6
333
126
E0000UV
ATC
NA
2.7
217.1
2259
11991
D01AE15
ATC
terbinafine; topical
4.8
184.5
681
1608
D07AC01
ATC
betamethasone; topical
2.5
176.0
1993
10688
11006
ICD-8 Finland
Dermatophytosis, Pedis
+∞
171.9
164
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.9
167.4
776
2265
TQW80
NOMESCO Finland
Local dermatologic skincare
8.4
162.9
376
479
A46
ICD-10 Finland
Erysipelas
2.8
123.8
922
3742
B35.2
ICD-10 Finland
Tinea manuum
74.9
121.1
138
19
J02AC02
ATC
itraconazole; systemic
2.5
106.4
997
4579
E000001
ATC
NA
2.4
105.3
1125
5528
L30.3
ICD-10 Finland
Infective dermatitis
5.3
100.6
325
647
D01AC02
ATC
miconazole; topical
3.2
97.8
565
1910
D07AC13
ATC
mometasone; topical
2.1
96.1
1486
8575
B35.9
ICD-10 Finland
Dermatophytosis, unspecified
32.9
94.4
125
39
D07XC01
ATC
betamethasone, combinations; topical
2.7
93.9
754
3153
D07AD01
ATC
clobetasol; topical
2.5
91.6
865
3953
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
86.8
827
3784
J01DB01
ATC
cefalexin; oral
2.1
85.0
3786
31639
1104A
ICD-9 Finland
Dermatophytosis, Of foot
+∞
83.6
80
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.0
82.3
534
1945
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
80.7
1356
7972
XQ848
NOMESCO Finland
Dermatological photography
5.6
78.1
241
453
H02AB06
ATC
prednisolone; systemic
1.8
77.7
2181
15307
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
76.0
2111
14731
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.8
71.2
320
880
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.9
68.8
236
500
D07BC01
ATC
betamethasone and antiseptics; topical
2.3
67.3
679
3163
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.3
66.3
679
3184
S18
ICPC
Laceration/cut
1.7
65.0
1987
14045
D02AE01
ATC
carbamide; topical
2.9
63.9
415
1500
L57.0
ICD-10 Finland
Actinic keratosis
2.5
63.9
551
2362
B35.0
ICD-10 Finland
Tinea barbae and tinea capitis
87.6
62.0
69
8
J01FF01
ATC
clindamycin; systemic
1.8
59.4
1296
8182
D07AB08
ATC
desonide; topical
2.4
59.0
561
2524
1101A
ICD-9 Finland
Dermatophytosis, Of nail
+∞
58.4
56
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
57.6
721
3689
R4180
NOMESCO Finland
Podiatric therapy
8.5
57.4
129
156
B35.8
ICD-10 Finland
Other dermatophytoses
23.8
57.2
82
35
SPAT1301
SPAT
No procedures
1.7
54.7
1477
9919
D01AC03
ATC
econazole; topical
2.8
54.4
370
1375
J01DA01
ATC
[U] cefalexin; systemic
1.6
54.0
2777
22197
SPAT1263
SPAT
Sampling
1.6
53.7
1918
13920
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.4
53.3
477
2076
J02AC01
ATC
fluconazole; systemic
1.7
53.1
1547
10597
E000003
ATC
NA
3.3
53.1
282
884
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
53.0
554
2605
11007
ICD-8 Finland
Dermatophytosis, Unguium
+∞
52.2
50
*
C03CA01
ATC
furosemide; systemic
1.7
51.8
1309
8587
L30.0
ICD-10 Finland
Nummular dermatitis
3.7
51.4
239
675
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
51.3
570
2754
L84
ICD-10 Finland
Corns and callosities
3.7
50.2
231
646
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.5
49.2
242
715
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.2
49.1
157
308
11004
ICD-8 Finland
Dermatophytosis, Inguinis
+∞
49.0
47
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
48.8
1914
14122
L30.4
ICD-10 Finland
Erythema intertrigo
7.1
48.8
123
178
E000002
ATC
NA
2.2
48.7
542
2619
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.5
48.6
416
1764
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
47.8
1354
9138
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
45.7
477
2234
D07CC01
ATC
betamethasone and antibiotics; topical
2.0
45.4
617
3244
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.5
45.3
227
680
L04AA06
ATC
mycophenolic acid; systemic
5.3
45.2
143
277
L04AX01
ATC
azathioprine; systemic
3.1
44.1
263
892
S97
ICPC
Chronic ulcer skin
2.7
43.2
316
1224
L85.89
ICD-10 Finland
Other specified epidermal thickening
24.7
43.2
61
25
D05AX52
ATC
calcipotriol, combinations; topical
2.7
42.7
318
1246
N02BE01
ATC
paracetamol; systemic, rectal
1.7
42.5
3813
33930
B07.9
ICD-10 Finland
Verruca simplex
3.6
41.5
198
571
D07AA02
ATC
hydrocortisone; topical
2.0
41.0
602
3252
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
40.5
1270
8730
D05BB02
ATC
acitretin; oral
3.9
40.4
172
451
H02AB04
ATC
methylprednisolone; systemic
1.9
40.3
652
3654
ZXC50
NOMESCO Finland
Cryotherapy
3.6
39.9
190
547
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
39.5
288
1114
P01BA02
ATC
hydroxychloroquine; oral
2.3
39.4
377
1689
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
39.4
624
3465
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
39.3
1362
9593
D09AB01
ATC
zinc bandage without supplements; topical
4.5
38.9
143
326
UJF32
NOMESCO Finland
Coloscopy
1.6
37.6
1122
7583
S29
ICPC
Skin symptom/complaint other
1.8
37.5
742
4446
R06AE07
ATC
cetirizine; oral
1.5
37.1
1736
13093
R50.9
ICD-10 Finland
Fever, unspecified
1.9
37.0
634
3617
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
4.1
36.7
147
365
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
36.6
625
3561
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
3.8
36.0
157
421
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
35.9
930
6038
L17
ICPC
Foot/toe symptom/complaint
1.6
35.8
1069
7213
127
Kela drug reimbursment
Transplant complication
4.9
35.6
119
246
XQ802
NOMESCO Finland
Epicutan test
3.0
35.5
210
710
J01MA02
ATC
ciprofloxacin; systemic
1.5
35.5
1673
12598
M79.6
ICD-10 Finland
Pain in limb
1.5
35.5
1477
10810
L30.8
ICD-10 Finland
Other specified dermatitis
3.9
35.5
151
396
J01CE08
ATC
benzathine benzylpenicillin; parenteral
6.7
35.4
92
140
E000006
ATC
NA
2.3
35.3
334
1486
SPAT1312
SPAT
General health counselling
1.6
35.3
1365
9824
E000007
ATC
NA
2.6
35.0
270
1078
A07EC01
ATC
sulfasalazine; oral, rectal
2.2
34.5
381
1823
R60.0
ICD-10 Finland
Localized oedema
2.0
34.2
499
2677
L85.3
ICD-10 Finland
Xerosis cutis
6.5
34.1
90
140
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
33.6
407
2027
SPAT1310
SPAT
Counselling related to known health issue
1.5
33.4
1358
9860
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
33.1
372
1793
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
33.0
1676
12767
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
5.3
32.8
103
199
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
32.8
220
809
B35
ICD-10 Finland
Dermatophytosis
8.3
32.6
73
89
D01AC07
ATC
tioconazole; topical
2.8
32.5
213
770
SPAT1153
SPAT
Removal of sutures
1.5
32.4
1405
10329
R06.0
ICD-10 Finland
Dyspnoea
1.6
32.2
1053
7242
A02BC02
ATC
pantoprazole; systemic
1.4
31.7
2761
23374
SPAT1260
SPAT
Consultation of another employee
1.7
31.6
780
4970
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
31.2
421
2191
L04AD01
ATC
ciclosporin; systemic
4.2
31.2
122
297
XQ845
NOMESCO Finland
Dermatoscopy
5.3
31.2
97
186
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
31.1
731
4593
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.2
31.0
331
1558
L04AA01
ATC
[U] ciclosporin; systemic
4.7
31.0
107
230
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.0
30.8
417
2170
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
3.9
30.6
130
341
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
30.5
725
4566
B35.5
ICD-10 Finland
Tinea imbricata
+∞
30.2
29
*
-
ICD-10 Finland
NA
3.4
30.1
149
444
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.6
29.7
139
396
Z94.0
ICD-10 Finland
Kidney transplant status
5.6
29.6
88
160
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
29.6
1671
12931
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.7
29.4
208
789
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
29.4
721
4580
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
29.2
1140
8146
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
29.2
357
1784
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.6
29.1
218
857
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
29.0
684
4297
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.1
28.9
161
524
M54.5
ICD-10 Finland
Low back pain
1.5
28.5
1296
9571
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
28.3
471
2648
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
28.3
510
2946
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
28.2
1387
10407
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
28.1
1348
10063
N03AX16
ATC
pregabalin; oral
1.6
28.1
971
6737
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
27.9
660
4143
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
27.9
1527
11706
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
27.9
988
6891
L20.0
ICD-10 Finland
Besnier prurigo
2.3
27.5
267
1201
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
27.4
2869
24779
R03AC02
ATC
salbutamol; inhalant
1.4
27.3
2093
17086
G47.3
ICD-10 Finland
Sleep apnoea
1.6
26.9
941
6537
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
26.9
291
1378
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
26.5
470
2694
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
26.5
426
2363
L28.0
ICD-10 Finland
Lichen simplex chronicus
5.7
26.3
76
134
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
4.3
26.0
97
227
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
25.8
355
1856
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
25.8
502
2965
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.2
25.6
137
434
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
25.5
2118
17459
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.7
25.4
527
3176
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
25.1
779
5246
S74
ICPC
Dermatophytosis
3.7
25.1
113
313
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
3.4
24.9
124
373
M25.5
ICD-10 Finland
Pain in joint
1.5
24.7
1071
7787
J01FA06
ATC
roxithromycin; oral
1.4
24.6
1601
12610
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
24.3
1744
13968
D02AX
ATC
Other emollients and protectives
2.9
24.2
151
531
SPAT1254
SPAT
Administration of medicine
1.7
24.2
611
3897
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
4.7
24.1
82
175
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
24.0
632
4076
QDH00
NOMESCO Finland
Avulsion of toe nail
13.8
24.0
41
30
N05BB01
ATC
hydroxyzine; systemic
2.2
24.0
253
1184
N03AX12
ATC
gabapentin; oral
1.6
23.9
622
4000
XQ899
NOMESCO Finland
Other assessment of skin
8.2
23.8
53
65
S76
ICPC
Skin infection other
2.3
23.8
231
1039
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.3
23.5
227
1020
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
23.4
318
1655
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
23.4
332
1758
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
23.3
619
3999
L04AA13
ATC
leflunomide; oral
3.1
23.1
128
416
D05AX02
ATC
calcipotriol; topical
2.4
23.1
202
862
ZX120
NOMESCO Finland
Intravenous
1.8
23.0
403
2297
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
23.0
1868
15239
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.6
22.9
175
693
M04AA01
ATC
allopurinol; systemic
1.7
22.9
568
3601
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.1
22.8
261
1267
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
22.6
1564
12400
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
120.6
22.6
24
*
K02.1
ICD-10 Finland
Caries of dentine
1.4
22.6
2250
18966
XQ800
NOMESCO Finland
Prick test
2.0
22.4
290
1481
AA1AD
NOMESCO Finland
CT of head and brain
1.5
22.3
970
7032
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.1
22.1
127
423
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.8
22.1
373
2098
L28.1
ICD-10 Finland
Prurigo nodularis
7.1
22.0
54
77
SPAT1325
SPAT
Vaccination
1.4
22.0
1401
10930
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
21.7
1888
15530
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.3
21.7
66
125
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
5.5
21.7
64
117
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
21.6
268
1343
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.0
21.5
130
448
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
21.4
156
606
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
4.2
21.3
82
199
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
9.2
21.2
44
48
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
21.2
261
1305
L82
ICD-10 Finland
Seborrhoeic keratosis
1.6
21.1
610
4018
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
21.1
1153
8734
J01AA02
ATC
doxycycline; systemic
1.4
20.9
3246
29190
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
20.9
229
1088
WZA90
NOMESCO Finland
Other doctors statement
1.5
20.9
897
6479
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.8
20.7
402
2371
A10AE04
ATC
insulin glargine; parenteral
1.8
20.6
408
2420
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
20.4
284
1493
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
6.0
20.3
56
94
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
20.3
1466
11653
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
20.3
666
4529
A02BC03
ATC
lansoprazole; oral
1.4
20.2
1160
8857
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
20.2
2517
21807
SPAT1229
SPAT
Assessment of need for aid
1.8
20.1
342
1932
T89
ICPC
Diabetes insulin dependent
2.4
19.9
173
739
ZY010
NOMESCO Finland
Hospital outpatient
2.3
19.8
192
865
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.8
19.8
389
2301
WX110
NOMESCO Finland
Local anesthesy
1.3
19.7
2794
24636
S22
ICPC
Nail symptom/complaint
2.0
19.7
250
1268
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
19.7
850
6135
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.0
19.6
247
1247
S21
ICPC
Skin texture symptom/complaint
1.6
19.5
492
3127
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
19.5
1317
10334
B01AA03
ATC
warfarin; systemic
1.5
19.4
839
6059
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.9
19.3
273
1442
B37.2
ICD-10 Finland
Candidiasis of skin and nail
6.8
19.2
48
71
L40.5
ICD-10 Finland
Arthropathic psoriasis
3.3
19.2
98
302
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
19.1
1080
8207
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
19.1
748
5289
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.9
19.0
120
426
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
19.0
281
1510
11009
ICD-8 Finland
Dermatophytosis, Unspecified
+∞
18.8
18
*
A10AE05
ATC
insulin detemir; parenteral
2.0
18.7
249
1286
M10.9
ICD-10 Finland
Gout, unspecified
1.9
18.7
296
1629
SPAT1262
SPAT
Handing over of treatment supplies
1.5
18.7
766
5466
N02AA05
ATC
oxycodone; systemic
1.6
18.6
580
3888
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
18.6
2159
18408
KMAK
NOMESCO Finland
NA
1.3
18.6
1990
16767
L60.9
ICD-10 Finland
Nail disorder, unspecified
4.0
18.6
75
191
M48.0
ICD-10 Finland
Spinal stenosis
1.6
18.5
479
3065
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.9
18.5
112
388
D06BB10
ATC
imiquimod; topical
2.2
18.4
187
861
L60.0
ICD-10 Finland
Ingrowing nail
2.2
18.3
184
843
SPAT1255
SPAT
Intravenous administration of medicine
1.9
18.3
278
1508
J01CA04
ATC
amoxicillin; systemic
1.3
18.3
3337
30376
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
2.3
18.3
176
792
M05BA04
ATC
alendronic acid; oral
1.9
18.2
290
1599
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.7
18.2
129
494
SPAT1216
SPAT
Assessment of functional ability
1.5
18.1
611
4175
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.5
18.0
145
595
RJ411
NOMESCO Finland
NA
6.4
18.0
47
74
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.8
18.0
117
426
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
18.0
1979
16715
H13
ICPC
Plugged feeling ear
1.5
17.8
723
5144
C07AB07
ATC
bisoprolol; oral
1.3
17.8
1919
16147
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
17.7
806
5863
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
17.7
2406
20922
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
17.7
417
2601
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
17.6
1049
8032
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
17.4
348
2066
B01AB05
ATC
enoxaparin; parenteral
1.4
17.4
1191
9336
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.5
17.3
138
564
L29.9
ICD-10 Finland
Pruritus, unspecified
2.9
17.3
107
377
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
17.3
283
1578
H02AB07
ATC
prednisone; oral
1.6
17.1
536
3596
R53
ICD-10 Finland
Malaise and fatigue
1.5
17.1
761
5512
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
17.0
280
1561
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
17.0
1105
8581
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.8
16.9
113
417
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
16.9
1147
8969
S06
ICPC
Rash localized
2.0
16.8
221
1138
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
16.7
278
1558
X58
ICD-10 Finland
Exposure to other specified factors
1.5
16.7
535
3606
A02BC01
ATC
omeprazole; systemic
1.4
16.6
1067
8263
E000004
ATC
NA
3.0
16.6
95
318
A10AA01
ATC
NA
2.6
16.4
122
481
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.0
16.4
226
1183
-1
NOMESCO Finland
NA
1.4
16.4
1228
9750
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.8
16.3
107
392
J01MA12
ATC
levofloxacin; systemic
1.5
16.3
731
5297
Z00.0
ICD-10 Finland
General medical examination
1.5
16.3
711
5126
A10AA02
ATC
NA
2.3
16.2
149
658
L04AB04
ATC
adalimumab; parenteral
3.1
16.1
87
281
N05AH04
ATC
quetiapine; oral
1.5
16.1
585
4057
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.6
16.0
115
443
ZXD05
NOMESCO Finland
Urgent procedure
1.3
16.0
1212
9629
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.2
15.9
82
256
L43.9
ICD-10 Finland
Lichen planus, unspecified
3.1
15.9
88
289
N06AX11
ATC
mirtazapine; oral
1.4
15.9
1172
9273
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
15.9
2797
25023
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
5.0
15.7
50
101
J01CF05
ATC
flucloxacillin; systemic
2.2
15.6
161
749
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.3
15.6
145
644
Z3231
NOMESCO Finland
Registered nurse
1.4
15.6
1075
8414
A07AA02
ATC
nystatin; oral
1.9
15.5
235
1276
J46
ICD-10 Finland
Status asthmaticus
2.6
15.5
112
435
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
15.4
1484
12211
A10AE06
ATC
insulin degludec; parenteral
2.4
15.4
131
556
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
15.3
243
1341
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
15.2
276
1593
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.9
15.2
91
316
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.8
15.1
285
1662
A06AD11
ATC
lactulose; oral
1.5
15.0
539
3723
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
15.0
506
3445
TK800
NOMESCO Finland
Hemodialysis
2.6
15.0
107
414
J01MA14
ATC
moxifloxacin; systemic
1.7
14.9
334
2051
137
Kela drug reimbursment
Uraemia requiring dialysis
4.4
14.9
53
121
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
14.9
440
2907
L28
ICPC
Limited function/disability (L)
1.5
14.9
591
4175
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
14.8
549
3818
EBA00
NOMESCO Finland
Extraction of tooth
1.3
14.8
1246
10044
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
14.8
2198
19151
L03
ICPC
Low back symptom/complaint
1.4
14.8
859
6524
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.6
14.7
365
2307
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
14.7
989
7693
L43.8
ICD-10 Finland
Other lichen planus
3.1
14.7
80
261
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.0
14.6
192
988
J01FA10
ATC
azithromycin; systemic
1.3
14.6
2168
18871
R42
ICD-10 Finland
Dizziness and giddiness
1.4
14.5
796
5978
M01CB01
ATC
sodium aurothiomalate; parenteral
3.4
14.5
70
209
M07.3
ICD-10 Finland
Other psoriatic arthropathies
3.6
14.5
65
183
J01AA07
ATC
tetracycline; systemic
1.5
14.5
514
3540
Z71.8
ICD-10 Finland
Other specified counselling
1.4
14.5
841
6385
R03BB04
ATC
tiotropium bromide; inhalant
1.6
14.5
379
2428
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.8
14.4
249
1414
A02BA02
ATC
ranitidine; systemic
1.4
14.4
752
5598
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
14.3
297
1783
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
14.3
322
1983
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
14.2
288
1719
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
14.2
201
1064
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
14.2
155
740
C08CA01
ATC
amlodipine; oral
1.3
14.2
1407
11596
A12AA04
ATC
calcium carbonate; oral
3.0
14.2
79
262
H04AA01
ATC
glucagon; nasal, parenteral
2.6
14.1
100
384
B86
ICD-10 Finland
Scabies
3.1
14.0
75
242
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.8
14.0
58
153
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
13.9
506
3503
E66.8
ICD-10 Finland
Other obesity
2.0
13.9
184
950
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.4
13.9
121
519
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.8
13.9
88
318
L73.8
ICD-10 Finland
Other specified follicular disorders
4.0
13.8
55
140
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
13.8
567
4030
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
13.8
1076
8557
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
13.8
294
1783
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
13.8
250
1442
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.3
13.7
126
555
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.4
13.7
120
516
H02AB09
ATC
hydrocortisone; systemic
2.6
13.6
98
381
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
13.6
188
990
SPAT1101
SPAT
Orthostatic test
2.0
13.6
175
896
Z2446
NOMESCO Finland
Social worker
1.8
13.5
246
1421
SPAT1058
SPAT
PEF monitoring instruction
1.7
13.5
309
1910
JN4AD
NOMESCO Finland
Body CT examination
1.7
13.5
299
1831
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
6.3
13.5
35
56
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
13.4
333
2105
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
13.4
287
1739
J05AB01
ATC
aciclovir; systemic
1.4
13.4
725
5426
A01
ICPC
Pain general/multiple sites
1.7
13.4
268
1596
L40.8
ICD-10 Finland
Other psoriasis
4.4
13.3
47
107
J05AB11
ATC
valaciclovir; oral
1.5
13.3
450
3067
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
13.3
638
4674
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
13.3
691
5136
RJ421
NOMESCO Finland
NA
6.6
13.2
33
50
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
13.2
459
3147
WW200
NOMESCO Finland
Immunization
2.3
13.2
117
509
E66.9
ICD-10 Finland
Obesity, unspecified
2.2
13.1
133
617
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
13.1
265
1584
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
6.5
13.0
33
51
N06AX21
ATC
duloxetine; oral
1.6
13.0
361
2348
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
13.0
388
2570
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.0
13.0
156
778
L04AB01
ATC
etanercept; parenteral
3.2
13.0
68
217
9751
FHL
Nail removal in the operating room or under anesthesia
28.4
12.9
17
6
A11CC03
ATC
alfacalcidol; systemic
2.4
12.9
104
431
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
2.3
12.9
120
532
SPAT1210
SPAT
Application of cast or individual aid
2.0
12.9
163
827
L60.3
ICD-10 Finland
Nail dystrophy
6.4
12.9
33
52
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
12.8
564
4061
A02BC05
ATC
esomeprazole; systemic
1.3
12.8
1536
12942
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.1
12.8
138
657
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
12.8
1404
11693
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
12.7
891
6958
SPAT1104
SPAT
Monitoring of emergency patient
1.7
12.7
251
1488
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.8
12.6
52
137
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
3.8
12.6
52
137
N06AA09
ATC
amitriptyline; systemic
1.6
12.6
357
2333
A28
ICPC
Limited function/disability NOS
1.4
12.6
540
3871
R03DC03
ATC
montelukast; oral
1.4
12.5
541
3879
WX290
NOMESCO Finland
Other blockade of nerve
1.3
12.5
1589
13475
1103A
ICD-9 Finland
Dermatophytosis, Of groin and perianal area
+∞
12.5
12
*
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.8
12.5
232
1351
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
12.5
896
7019
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
12.5
235
1373
Z08
ICPC
Social welfare problem
3.3
12.4
62
191
SPAT1240
SPAT
Therapeutic discussion
1.6
12.4
336
2169
ZZA00
NOMESCO Finland
Split skin graft
2.2
12.4
128
598
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.1
12.4
135
646
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.7
12.3
85
322
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.0
12.3
69
231
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
12.3
504
3575
SPAT1097
SPAT
Recording of ECG
1.4
12.3
566
4108
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.6
12.3
89
348
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.9
12.3
187
1018
L08.0
ICD-10 Finland
Pyoderma
3.8
12.3
51
136
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.0
12.2
156
795
RJ420
NOMESCO Finland
NA
5.3
12.2
36
68
SPAT1211
SPAT
Application of soft bandage
1.6
12.2
335
2176
A41.9
ICD-10 Finland
Sepsis, unspecified
2.0
12.2
145
721
R06AX13
ATC
loratadine; oral
1.5
12.1
502
3569
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
12.1
1088
8806
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.5
12.1
92
370
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
4.3
12.1
44
104
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
12.1
379
2541
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
4.2
12.0
45
109
P01AB01
ATC
metronidazole; oral, rectal
1.3
12.0
1415
11870
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
12.0
319
2053
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.3
12.0
112
501
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
11.9
192
1069
B05DA
ATC
Isotonic solutions
4.5
11.9
41
92
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.4
11.9
56
166
A01AB09
ATC
miconazole; local oral
1.6
11.9
310
1988
L50.8
ICD-10 Finland
Other urticaria
3.0
11.8
66
221
M79.1
ICD-10 Finland
Myalgia
1.5
11.8
439
3056
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
6.1
11.8
31
51
I50.0
ICD-10 Finland
Congestive heart failure
1.7
11.8
269
1663
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.8
11.7
194
1089
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.7
11.7
50
137
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
11.7
883
6968
N06AB04
ATC
citalopram; systemic
1.4
11.6
756
5824
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
5.0
11.6
36
72
M54.6
ICD-10 Finland
Pain in thoracic spine
1.7
11.6
222
1301
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
11.6
871
6861
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
11.6
907
7188
L12.0
ICD-10 Finland
Bullous pemphigoid
4.7
11.6
38
81
M03BX02
ATC
tizanidine; oral
1.2
11.6
2368
21171
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
11.5
265
1641
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
2.7
11.5
78
295
R06AX27
ATC
desloratadine; oral
1.3
11.5
892
7062
ZXA00
NOMESCO Finland
Right side
1.3
11.5
1017
8205
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
3.4
11.5
55
165
SPAT1234
SPAT
Support of social functional capacity
1.8
11.5
190
1066
R01AD08
ATC
fluticasone; nasal
1.3
11.5
1000
8054
SDA02
NOMESCO Finland
Parodonthologic therapy
1.3
11.4
1162
9554
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.8
11.4
71
254
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
11.4
410
2832
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
11.4
849
6682
NHQ40
NOMESCO Finland
Amputation of toe
2.7
11.4
79
301
R05
ICD-10 Finland
Cough
1.4
11.4
684
5206
L21.0
ICD-10 Finland
Seborrhoea capitis
3.4
11.4
53
156
SPAT1053
SPAT
Memory test
1.4
11.3
561
4128
R03BA08
ATC
ciclesonide; inhalant
1.6
11.3
282
1785
K07.60
ICD-10 Finland
Snapping jaw
2.0
11.2
150
780
SFA00
NOMESCO Finland
Small filling
1.5
11.2
459
3256
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
5.3
11.1
33
63
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
11.1
916
7310
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.8
11.1
69
245
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
11.1
219
1298
D07AB01
ATC
clobetasone; topical
2.2
11.1
116
546
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.8
11.1
46
123
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.3
11.1
863
6837
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
11.1
278
1765
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
11.0
284
1814
R52.2
ICD-10 Finland
Other chronic pain
2.1
11.0
120
575
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.7
11.0
225
1349
R11
ICD-10 Finland
Nausea and vomiting
1.6
11.0
271
1712
D05AX03
ATC
calcitriol; topical
2.9
11.0
66
233
Z00.8
ICD-10 Finland
Other general examinations
1.6
10.9
260
1627
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
10.9
1506
12849
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.2
10.9
107
491
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.3
10.9
101
449
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.9
10.9
63
216
L50.9
ICD-10 Finland
Urticaria, unspecified
2.1
10.9
122
594
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
5.3
10.8
32
61
M01AC06
ATC
meloxicam; systemic, rectal
1.3
10.8
1335
11235
R03BA01
ATC
beclometasone; inhalant
1.4
10.8
493
3571
WZC30
NOMESCO Finland
Teaching
1.4
10.8
485
3506
QDH05
NOMESCO Finland
Correction of deformity of toe nail
7.2
10.7
25
35
J45
ICD-10 Finland
Asthma
1.5
10.7
322
2138
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.2
10.7
108
501
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
10.7
317
2096
B37.8
ICD-10 Finland
Candidiasis of other sites
21.5
10.7
15
7
T90
ICPC
Diabetes non-insulin dependent
1.3
10.6
890
7116
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
10.6
267
1697
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
10.6
276
1771
B36.0
ICD-10 Finland
Pityriasis versicolor
3.5
10.5
47
134
A98
ICPC
Health maint/preventive medicine
1.4
10.5
4230
40784
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.0
10.5
128
642
N05BA04
ATC
oxazepam; oral
1.3
10.5
849
6750
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
3.7
10.5
44
119
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
10.5
452
3238
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.0
10.5
123
608
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.5
10.5
81
330
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.8
10.4
179
1016
L43.0
ICD-10 Finland
Hypertrophic lichen planus
4.6
10.4
35
77
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.9
10.4
154
831
RJ424
NOMESCO Finland
NA
+∞
10.4
10
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
10.4
315
2094
L20.8
ICD-10 Finland
Other atopic dermatitis
3.6
10.3
45
126
L30.2
ICD-10 Finland
Cutaneous autosensitization
32.6
10.3
13
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
10.3
388
2704
R01AD01
ATC
beclometasone; nasal
1.4
10.3
512
3766
R51.80
ICD-10 Finland
Headache
1.4
10.3
480
3492
L93.0
ICD-10 Finland
Discoid lupus erythematosus
5.1
10.3
31
61
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.0
10.3
56
186
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.0
10.3
56
186
R01AD12
ATC
fluticasone furoate; nasal
1.3
10.2
977
7946
L88
ICPC
Rheumatoid/seropositive arthritis
2.0
10.2
130
664
ZXC15
NOMESCO Finland
Use of photodynamic technique
2.8
10.2
64
230
205
Kela drug reimbursment
Chronic hypertension
1.3
10.2
1089
8987
L50.3
ICD-10 Finland
Dermatographic urticaria
2.8
10.2
62
221
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
3.0
10.2
56
187
ND1AE
NOMESCO Finland
Wrist ultrasound examination
6.6
10.2
25
38
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.2
10.1
102
474
D82
ICPC
Teeth/gum disease
1.3
10.1
1201
10043
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
10.1
211
1272
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.8
10.1
167
939
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
4.7
10.1
33
71
S01
ICPC
Pain/tenderness of skin
1.8
10.1
157
865
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
6.9
10.1
24
35
H3603, E113
ICD-10 Finland
NA
3.4
10.0
47
140
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
2.0
10.0
126
641
C08CA02
ATC
felodipine; oral
1.5
10.0
350
2402
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
10.0
168
951
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.3
10.0
85
366
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
5.1
10.0
30
59
L60.8
ICD-10 Finland
Other nail disorders
3.5
10.0
44
125
L71.8
ICD-10 Finland
Other rosacea
3.0
10.0
57
193
J01AA04
ATC
lymecycline; systemic
1.4
10.0
428
3062
C10AC01
ATC
colestyramine; oral
2.2
10.0
98
451
L14
ICPC
Leg/thigh symptom/complaint
1.6
9.9
255
1626
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
9.9
440
3171
B01AC04
ATC
clopidogrel; oral
1.4
9.9
606
4619
C03DA01
ATC
spironolactone; oral
1.5
9.9
380
2663
XJH00
NOMESCO Finland
Transanal ultrasonography
1.6
9.8
265
1710
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.5
9.8
341
2334
L99
ICPC
Musculoskeletal disease other
2.6
9.8
70
273
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
2.9
9.8
58
203
S70.0
ICD-10 Finland
Contusion of hip
2.0
9.8
125
641
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
9.8
942
7667
R96
ICPC
Asthma
1.5
9.8
289
1908
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.1
9.8
105
503
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.9
9.8
131
684
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
5.4
9.8
28
52
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.7
9.7
187
1101
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.3
9.7
88
388
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.1
9.7
111
545
N05CF01
ATC
zopiclone; oral
1.3
9.7
1176
9851
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.5
9.7
73
294
K08.3
ICD-10 Finland
Retained dental root
1.6
9.7
259
1673
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.9
9.7
56
193
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.6
9.7
225
1401
6929X
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]
7.8
9.6
21
27
M81.4
ICD-10 Finland
Drug-induced osteoporosis
6.0
9.5
25
42
R01AD09
ATC
mometasone; nasal
1.2
9.5
1594
13846
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.2
9.5
97
455
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.6
9.5
258
1675
N05CD07
ATC
temazepam; oral
1.4
9.5
439
3190
SPAT1043
SPAT
Audiometry
1.4
9.4
380
2688
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
9.4
165
948
SBA00
NOMESCO Finland
Microbiological examinations
2.3
9.4
86
382
D07CB01
ATC
triamcinolone and antibiotics; topical
2.3
9.4
81
351
M02AA07
ATC
piroxicam; topical
1.2
9.4
1335
11385
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
2.4
9.4
77
324
11008
ICD-8 Finland
Dermatophytosis, Alia
+∞
9.4
9
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.8
9.4
153
857
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.2
9.4
92
425
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
9.4
549
4153
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
9.3
641
4974
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
3.9
9.3
36
92
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.6
9.3
40
112
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
9.2
848
6854
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
9.2
235
1498
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.2
9.2
90
413
SPAT1285
SPAT
Provision of consultation response
1.7
9.2
197
1199
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.5
9.2
354
2482
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
9.2
476
3529
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.7
9.1
197
1202
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
4.2
9.1
33
79
A07EA06
ATC
budesonide; oral, local oral
2.0
9.1
115
588
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.8
9.1
145
806
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.5
9.1
69
280
A41.8
ICD-10 Finland
Other specified sepsis
2.5
9.1
69
280
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.3
9.1
81
357
R35
ICD-10 Finland
Polyuria
1.6
9.0
242
1562
TGC00
NOMESCO Finland
Bronchial lavation
2.1
9.0
97
467
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
9.0
738
5872
F61.0
ICD-10 Finland
Mixed personality disorders
2.6
9.0
61
232
M01AE02
ATC
naproxen; oral, rectal
1.2
9.0
2120
19037
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
8.9
188
1137
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.9
8.9
132
715
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.8
8.9
160
925
H3603, E103
ICD-10 Finland
NA
3.1
8.9
47
154
L95.8
ICD-10 Finland
Other vasculitis limited to skin
5.7
8.9
24
42
N30.0
ICD-10 Finland
Acute cystitis
1.4
8.9
420
3063
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
8.8
445
3283
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
3.1
8.8
47
155
H3600, E103
ICD-10 Finland
NA
3.1
8.8
47
155
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.7
8.8
161
938
C07AB02
ATC
metoprolol; systemic
1.3
8.8
763
6122
D07XB05
ATC
dexamethasone, combinations; topical
2.1
8.8
95
459
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.6
8.8
238
1545
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.1
8.7
94
453
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
8.7
424
3108
XKD00
NOMESCO Finland
Uroflowmetry
1.3
8.6
659
5187
Z01.2
ICD-10 Finland
Dental examination
1.2
8.6
1434
12413
Z3226
NOMESCO Finland
Physiotherapist
1.3
8.6
655
5153
S08
ICPC
Skin colour change
1.7
8.6
173
1035
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.7
8.6
185
1130
D06BX01
ATC
metronidazole; topical
1.5
8.6
323
2254
Z94.1
ICD-10 Finland
Heart transplant status
6.1
8.6
22
36
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.7
8.6
176
1058
A04
ICPC
Weakness/tiredness general
1.4
8.6
424
3118
R07.3
ICD-10 Finland
Other chest pain
1.5
8.6
321
2238
K59.0
ICD-10 Finland
Constipation
1.7
8.6
181
1099
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.8
8.6
54
196
RJ422
NOMESCO Finland
NA
9.0
8.5
17
19
R03BA05
ATC
fluticasone; inhalant
1.3
8.5
601
4678
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.7
8.5
162
957
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.8
8.5
136
761
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.7
8.4
161
947
H03AA01
ATC
levothyroxine sodium; systemic
1.3
8.4
746
5992
UKC02
NOMESCO Finland
Cystoscopy
1.3
8.4
617
4831
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
8.4
943
7807
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
3.9
8.4
33
86
C05AA08
ATC
fluocortolone; rectal, topical
1.4
8.4
506
3842
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
8.4
579
4495
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
8.4
355
2538
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.2
8.4
80
367
R03BA02
ATC
budesonide; inhalant
1.3
8.3
581
4514
1102A
ICD-9 Finland
Dermatophytosis, Of hand
+∞
8.3
8
*
11299
ICD-8 Finland
Moniliasis
+∞
8.3
8
*
11003
ICD-8 Finland
Dermatophytosis, Corporis
+∞
8.3
8
*
S99
ICPC
Skin disease other
2.3
8.3
76
339
J01FA01
ATC
erythromycin; systemic
1.4
8.3
448
3340
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
8.3
358
2564
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
3.8
8.3
33
87
L04AB06
ATC
golimumab; parenteral
3.7
8.3
34
92
L60.1
ICD-10 Finland
Onycholysis
3.3
8.3
39
118
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
8.3
220
1419
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
8.3
1421
12331
WX892
NOMESCO Finland
Monitored bed care
1.5
8.3
286
1963
H26.02
ICD-10 Finland
Presenil cataract
2.0
8.3
98
492
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
8.2
290
1998
R06AX22
ATC
ebastine; oral
1.3
8.2
531
4077
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
8.2
633
4988
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.8
8.2
33
88
K07
ICPC
Swollen ankles/oedema
1.7
8.2
150
875
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
8.2
167
1004
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
8.2
1399
12136
L71.9
ICD-10 Finland
Rosacea, unspecified
2.2
8.1
80
370
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
6.0
8.1
21
35
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
5.7
8.1
22
39
SPAT1252
SPAT
Overall medication plan or its review
1.5
8.1
255
1714
SPAT1081
SPAT
Cardiorespiratory global assessment
1.6
8.1
212
1362
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
8.1
221
1435
R02
ICPC
Shortness of breath/dyspnoea
1.4
8.1
402
2957
Z94.2
ICD-10 Finland
Lung transplant status
6.8
8.0
19
28
N05AA02
ATC
levomepromazine; systemic
1.7
8.0
147
857
L70.0
ICD-10 Finland
Acne vulgaris
2.4
8.0
63
262
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
2.5
8.0
59
237
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
8.0
510
3910
6929B
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]
6.3
8.0
20
32
R03AC03
ATC
terbutaline; inhalant
1.4
8.0
457
3446
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
8.0
223
1459
J01CR50
ATC
combinations of penicillins; systemic
7.2
7.9
18
25
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
3.3
7.9
38
117
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.6
7.9
53
203
S91.3
ICD-10 Finland
Open wound of other parts of foot
2.1
7.9
86
416
N06AB03
ATC
fluoxetine; oral
1.4
7.9
404
2987
H26.3
ICD-10 Finland
Drug-induced cataract
3.8
7.9
31
81
R13
ICD-10 Finland
Dysphagia
1.6
7.9
218
1422
NH3BG
NOMESCO Finland
MRI of foot
3.7
7.9
32
86
GD1AD
NOMESCO Finland
Thorax CT examination
1.7
7.9
156
930
ZX108
NOMESCO Finland
Inhalation
3.3
7.9
37
112
B03XA02
ATC
darbepoetin alfa; parenteral
2.2
7.9
74
337
M01AH02
ATC
rofecoxib; oral
1.4
7.9
462
3497
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
7.9
359
2601
L13
ICPC
Hip symptom/complaint
1.3
7.9
509
3911
R03DA04
ATC
theophylline; systemic, rectal
1.7
7.8
171
1051
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
7.8
244
1635
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
7.8
109
581
N06AX16
ATC
venlafaxine; oral
1.4
7.8
422
3152
H26.2
ICD-10 Finland
Complicated cataract
2.6
7.8
52
199
A02BX02
ATC
sucralfate; oral
1.7
7.8
143
836
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
2.7
7.8
50
186
WQ020
NOMESCO Finland
NA
9.4
7.8
15
16
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.5
7.8
251
1699
C09AA02
ATC
enalapril; systemic
1.3
7.8
736
5965
L29.8
ICD-10 Finland
Other pruritus
2.9
7.8
43
147
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
1.9
7.7
113
614
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
7.7
124
693
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.7
7.7
142
829
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.7
7.7
152
906
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
3.5
7.7
34
99
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.4
7.6
315
2239
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.4
7.6
63
268
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.8
7.6
123
687
C08CA05
ATC
nifedipine; systemic
1.5
7.6
221
1458
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.3
7.6
66
288
R05
ICPC
Cough
1.3
7.6
744
6048
G04BD08
ATC
solifenacin; oral
1.5
7.6
222
1468
D11AH01
ATC
tacrolimus; topical
3.3
7.6
35
105
J01FA09
ATC
clarithromycin; systemic
1.2
7.6
1074
9120
E66.00
ICD-10 Finland
Metabolic syndrome
1.6
7.6
186
1179
J04BA02
ATC
dapsone; oral
4.2
7.6
27
65
WX213
NOMESCO Finland
Lower leg blockade
3.1
7.6
39
127
M01AX05
ATC
glucosamine; oral
1.3
7.6
687
5534
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.3
7.6
63
271
V03AE01
ATC
polystyrene sulfonate; oral
2.6
7.6
53
208
S09
ICPC
Infected finger/toe
1.9
7.6
105
560
A10BH01
ATC
sitagliptin; oral
1.4
7.5
338
2440
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.6
7.5
174
1085
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
7.5
904
7536
D07AC14
ATC
methylprednisolone aceponate; topical
1.7
7.5
152
913
S19
ICPC
Skin injury other
1.7
7.5
142
839
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.0
7.5
87
432
K83.0
ICD-10 Finland
Cholangitis
2.5
7.5
56
228
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.9
7.5
106
568
WQ021
NOMESCO Finland
NA
7.1
7.5
17
24
Z49.2
ICD-10 Finland
Other dialysis
3.5
7.5
33
96
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
4.0
7.4
28
71
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
7.4
274
1905
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.0
7.4
39
129
R06.5
ICD-10 Finland
Mouth breathing
1.4
7.4
309
2200
B02
ICD-10 Finland
Zoster [herpes zoster]
1.8
7.4
121
680
ZXA05
NOMESCO Finland
Left side
1.2
7.4
935
7835
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.0
7.4
87
437
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
7.4
593
4700
S17
ICPC
Abrasion/scratch/blister
2.1
7.4
84
413
L40.9
ICD-10 Finland
Psoriasis, unspecified
2.4
7.4
61
260
H02AB08
ATC
triamcinolone; systemic
4.5
7.4
24
53
M01AX17
ATC
nimesulide; oral
1.2
7.4
872
7256
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.5
7.4
231
1551
WX408
NOMESCO Finland
General anesthesy, balanced
1.2
7.3
984
8300
N06AA12
ATC
doxepin; systemic
1.6
7.3
179
1134
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
3.7
7.3
30
82
A05
ICPC
Feeling ill
1.6
7.3
174
1095
03599
ICD-8 Finland
Erysipelas
4.3
7.3
25
58
L85.1
ICD-10 Finland
Acquired keratosis [keratoderma] palmaris et plantaris
8.4
7.3
15
18
C02AC05
ATC
moxonidine; oral
1.6
7.3
162
999
B01AB04
ATC
dalteparin; parenteral
1.6
7.3
167
1039
11005
ICD-8 Finland
Dermatophytosis, Manuum
+∞
7.3
7
*
RJ413
NOMESCO Finland
NA
+∞
7.3
7
*
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
7.3
145
869
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
7.3
155
945
N03AE01
ATC
clonazepam; systemic
1.6
7.3
194
1258
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.3
7.2
746
6105
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.1
7.2
77
372
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.5
7.2
234
1582
NHG82
NOMESCO Finland
Fusion of other tarsal joint
3.0
7.2
38
126
M01AH05
ATC
etoricoxib; oral
1.2
7.2
2203
20095
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.7
7.2
136
804
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.4
7.2
60
257
C10AA05
ATC
atorvastatin; oral
1.2
7.2
1454
12783
M01CB03
ATC
auranofin; oral
3.2
7.2
35
110
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.4
7.2
55
228
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
7.2
164
1020
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
7.2
282
1986
J02AB02
ATC
ketoconazole; oral
1.9
7.2
96
507
H3601, E103
ICD-10 Finland
NA
2.9
7.1
41
141
Q82.82
ICD-10 Finland
Inherited keratosis palmaris et plantaris
30.0
7.1
9
*
S75
ICPC
Moniliasis/candidiasis skin
3.6
7.1
30
84
NH3CG
NOMESCO Finland
Extensive MRI of foot
3.8
7.1
28
74
S87
ICPC
Dermatitis/atopic eczema
2.1
7.1
73
346
SPAT1151
SPAT
Treatment of major wounds
2.5
7.1
53
214
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.5
7.1
53
214
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.0
7.1
87
445
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.9
7.1
41
143
R06AE09
ATC
levocetirizine; oral
1.3
7.1
456
3501
S22.3
ICD-10 Finland
Fracture of rib
1.5
7.1
232
1574
B37.08
ICD-10 Finland
Other candidal stomatitis
5.3
7.1
20
38
L01BB01
ATC
NA
6.0
7.1
18
30
C10AA03
ATC
pravastatin; oral
1.5
7.1
248
1708
K05.30
ICD-10 Finland
Periodontitis complex
1.3
7.1
426
3236
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
5.6
7.0
19
34
S06.0
ICD-10 Finland
Concussion
1.4
7.0
338
2475
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.3
7.0
423
3211
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
10.0
7.0
13
13
G04BD12
ATC
mirabegron; oral
1.4
7.0
335
2447
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
7.0
1565
13878
J01EA01
ATC
trimethoprim; systemic
1.3
7.0
773
6375
A10BH05
ATC
linagliptin; oral
1.6
7.0
164
1028
K51.5
ICD-10 Finland
Left sided colitis
1.9
7.0
90
466
L04AA17
ATC
[U] adalimumab; parenteral
4.7
7.0
22
47
J01MA06
ATC
norfloxacin; oral
1.3
7.0
420
3192
C09AA05
ATC
ramipril; oral
1.2
7.0
926
7797
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
3.2
7.0
34
107
J01XC01
ATC
fusidic acid; systemic
2.4
7.0
56
237
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.2
7.0
797
6603
ZXA10
NOMESCO Finland
Bilateral
1.3
7.0
647
5224
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.2
7.0
67
309
M66.0
ICD-10 Finland
Rupture of popliteal cyst
2.4
6.9
53
219
V03AE02
ATC
sevelamer; oral
3.8
6.9
27
71
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
3.8
6.9
27
71
L73.9
ICD-10 Finland
Follicular disorder, unspecified
4.4
6.9
23
52
N05BA01
ATC
diazepam; systemic, rectal
1.3
6.9
447
3433
S80.0
ICD-10 Finland
Contusion of knee
1.6
6.9
193
1263
C01DA14
ATC
isosorbide mononitrate; oral
1.3
6.9
543
4288
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.9
6.9
100
543
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.7
6.9
138
827
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.4
6.9
55
231
AN1
HP
Coronary angiography
1.3
6.9
444
3411
N05AF03
ATC
chlorprothixene; systemic
1.9
6.9
94
501
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.5
6.9
263
1845
A10BJ02
ATC
liraglutide; parenteral
2.0
6.9
83
422
H26.4
ICD-10 Finland
After-cataract
1.4
6.9
274
1937
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.8
6.9
103
564
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
4.0
6.9
25
62
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
1.9
6.9
89
464
C08CA13
ATC
lercanidipine; oral
1.3
6.8
452
3483
J20
ICD-10 Finland
Acute bronchitis
1.4
6.8
301
2168
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
1.9
6.8
91
480
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.6
6.8
45
172
L71.0
ICD-10 Finland
Perioral dermatitis
3.0
6.8
37
126
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.3
6.8
31
93
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.0
6.8
80
402
P20
ICPC
Memory disturbance
1.3
6.8
401
3038
N18.8
ICD-10 Finland
Other chronic renal failure
1.8
6.8
99
541
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
3.5
6.8
29
83
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.6
6.8
155
967
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
5.3
6.8
19
36
RJ210
NOMESCO Finland
NA
5.3
6.8
19
36
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.1
6.8
73
355
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
3.6
6.7
28
78
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
3.1
6.7
34
110
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
3.7
6.7
27
73
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.8
6.7
104
577
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
6.7
510
4009
K05.31
ICD-10 Finland
Periodontitis pronounced
1.4
6.7
336
2475
C09CA01
ATC
losartan; oral
1.2
6.7
863
7241
CKC12
NOMESCO Finland
Photocoagulation of retina
1.6
6.7
146
896
M10.3
ICD-10 Finland
Gout due to impairment of renal function
4.1
6.7
24
59
QX_2
NOMESCO Finland
Other diagnostic procedures of skin
22.5
6.7
9
*
M02AA10
ATC
ketoprofen; topical
1.3
6.6
537
4256
M54.3
ICD-10 Finland
Sciatica
1.5
6.6
188
1237
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.7
6.6
132
795
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
6.6
388
2937
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
2.5
6.6
50
205
D19
ICPC
Teeth/gum symptom/complaint
1.2
6.6
859
7220
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
6.6
216
1468
K74.3
ICD-10 Finland
Primary biliary cirrhosis
4.0
6.6
24
60
R32
ICD-10 Finland
Unspecified urinary incontinence
1.9
6.6
85
445
JN4BD
NOMESCO Finland
Extensive body CT
1.3
6.6
386
2922
R21
ICPC
Throat symptom/complaint
1.3
6.6
561
4485
L03.8
ICD-10 Finland
Cellulitis of other sites
3.6
6.6
27
75
R05FB02
ATC
cough suppressants and expectorants
1.2
6.5
1365
12011
M03BC01
ATC
orphenadrine (citrate); systemic
1.2
6.5
760
6306
H01.0
ICD-10 Finland
Blepharitis
1.6
6.5
164
1048
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
2.4
6.5
53
226
A07EC02
ATC
mesalazine; oral, rectal
1.6
6.5
175
1138
L08
ICPC
Shoulder symptom/complaint
1.3
6.5
635
5160
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
6.8
6.5
15
22
RJ511
NOMESCO Finland
NA
6.8
6.5
15
22
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
1.9
6.5
88
465
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.7
6.5
42
157
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.5
6.5
190
1261
SPAT1307
SPAT
Psychosocial counselling and guidance
1.6
6.5
168
1080
H61.2
ICD-10 Finland
Impacted cerumen
1.5
6.5
191
1266
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
6.5
173
1124
S10
ICPC
Boil/carbuncle
1.6
6.5
176
1148
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.8
6.5
100
556
XG466
NOMESCO Finland
Sleep oxymetry
1.7
6.5
118
689
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.0
6.5
75
374
L13.0
ICD-10 Finland
Dermatitis herpetiformis
3.9
6.5
24
61
NHG20
NOMESCO Finland
Fusion of talocrural joint
3.6
6.5
27
76
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.1
6.4
68
326
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.8
6.4
109
624
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.7
6.4
130
784
NH1AD
NOMESCO Finland
Ankle and foot CT
2.1
6.4
70
340
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.4
6.4
301
2197
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
2.0
6.4
79
404
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
4.2
6.4
22
52
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
7.4
6.4
14
19
N04BC05
ATC
pramipexole; oral
1.5
6.4
234
1625
H01
ICPC
Ear pain/earache
1.4
6.4
314
2306
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.6
6.4
145
904
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.8
6.4
107
611
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.5
6.4
196
1312
B36.8
ICD-10 Finland
Other specified superficial mycoses
4.7
6.4
20
43
69282
ICD-8 Finland
Other eczema and dermatitis, E microbis
4.7
6.4
20
43
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.6
6.3
149
934
R03AC13
ATC
formoterol; inhalant
1.6
6.3
149
934
N03AX09
ATC
lamotrigine; oral
1.7
6.3
134
817
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.5
6.3
226
1564
D01BA01
ATC
griseofulvin; oral; topical
6.5
6.3
15
23
L01BB05
ATC
fludarabine; systemic
8.1
6.3
13
16
T82
ICPC
Obesity
1.8
6.3
108
621
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.8
6.3
102
575
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
11.0
6.3
11
10
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
6.3
303
2219
TAKUU
NOMESCO Finland
NA
2.7
6.3
38
139
WKPAL
NOMESCO Finland
NA
2.1
6.3
67
325
C10AA01
ATC
simvastatin; oral
1.2
6.2
1673
15030
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.7
6.2
113
662
N05AH03
ATC
olanzapine; systemic
1.5
6.2
176
1156
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
6.2
586
4739
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.2
6.2
1257
11024
F60.9
ICD-10 Finland
Personality disorder, unspecified
2.6
6.2
42
164
SPAT1147
SPAT
Destruction of skin lesion with external methods
2.1
6.2
65
314
L16
ICPC
Ankle symptom/complaint
1.4
6.2
318
2353
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
2.8
6.2
36
127
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.7
6.2
123
741
A10BA02
ATC
metformin; oral
1.2
6.2
1025
8822
N02AC04
ATC
dextropropoxyphene; oral
1.7
6.2
126
762
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.7
6.2
126
765
C03AA03
ATC
hydrochlorothiazide; oral
1.4
6.1
325
2418
RJ410
NOMESCO Finland
NA
4.5
6.1
20
45
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
2.7
6.1
40
151
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
5.7
6.1
16
28
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
6.1
514
4095
QCH00
NOMESCO Finland
Avulsion of finger nail
7.7
6.1
13
17
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
6.1
108
628
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.2
6.1
790
6626
S04
ICPC
Lump/swelling localized
1.4
6.1
283
2060
N03AG01
ATC
valproic acid; systemic, rectal
1.5
6.1
193
1305
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
3.4
6.1
27
80
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
2.7
6.1
37
136
G04CA02
ATC
tamsulosin; oral
1.2
6.1
927
7910
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.5
6.1
220
1529
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
2.7
6.0
38
143
R22.7
ICD-10 Finland
Localized swelling, mass and lump, multiple sites
8.6
6.0
12
14
C10AA04
ATC
fluvastatin; oral
1.4
6.0
297
2185
R5140
NOMESCO Finland
Monitoring the use of the aid
1.3
6.0
369
2812
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.5
6.0
44
179
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
2.6
6.0
40
154
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
2.6
6.0
41
161
R10.0
ICD-10 Finland
Acute abdomen
1.8
6.0
102
586
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.5
6.0
174
1152
207
Kela drug reimbursment
Chronic arrhythmias
1.3
6.0
511
4076
P99
ICPC
Psychological disorders other
2.0
6.0
74
379
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
10.0
6.0
11
11
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
1.7
6.0
121
730
T78.4
ICD-10 Finland
Allergy, unspecified
1.7
6.0
121
731

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000494) Fungus identified in Specimen by Culture
1690
4920
4.60
307.65
1.7
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
3042
21385
2.01
127.64
8.7
5.8
e9/l
0.0
0.0
0.12
2745
18407
(3001604) Monocytes [#/volume] in Blood
3022
21295
2.00
124.72
8.7
5.8
e9/l
0.6
0.6
0.20
2728
18299
(3013115) Eosinophils [#/volume] in Blood
3094
22099
1.98
121.38
9.0
6.0
e9/l
0.2
0.2
1.57
2820
19303
(3013650) Neutrophils [#/volume] in Blood by Automated count
3358
24695
2.01
120.82
11.8
9.0
e9/l
4.3
4.2
2.61
3070
21457
(3019198) Lymphocytes [#/volume] in Blood
3071
21901
1.98
120.74
8.8
5.8
e9/l
1.9
1.9
0.97
2802
19190
(3007853) Bacteria identified in Skin by Aerobe culture
1052
5070
2.35
119.16
2.3
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
819
3522
2.57
119.10
5.0
3.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1514
9159
1.92
90.64
7.2
4.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2567
18694
1.73
80.19
6.2
5.0
g/l
35.0
35.4
3.21
2426
17416
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3992
33061
1.88
79.01
10.3
7.6
u/l
79.9
78.9
0.51
3800
31163
(40768443) Skin Pathology biopsy report
461
1818
2.68
78.41
1.3
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1802
12223
1.72
70.07
5.4
4.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1417
9011
1.79
68.93
5.8
3.9
kg/l
1.0
1.0
0.41
144
1343
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
701
3526
2.14
68.44
2.9
2.7
ml/min/173m2
62.1
65.3
1.22
317
1397
(3013707) Erythrocyte sedimentation rate by Westergren method
3780
31328
1.75
67.92
6.0
4.0
mm/h
13.3
12.2
4.38
3538
28983
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
947
5346
1.94
67.08
12.0
7.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2797
21502
1.65
66.05
8.9
6.9
mmol/l
1.2
1.2
2.59
2401
18215
(3029937) Albumin [Presence] in Urine by Test strip
1656
11129
1.71
65.66
6.0
3.9
estimate
0.0
0.0
0.19
478
3711
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2584
19493
1.64
65.61
8.1
6.2
mmol/l
1.2
1.2
2.30
2356
17714
(3011397) Hemoglobin [Presence] in Urine by Test strip
1480
9697
1.73
64.02
5.3
3.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1041
6174
1.86
62.93
2.5
2.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2667
20517
1.61
60.69
5.1
3.5
estimate
0.0
0.0
1.08
475
3804
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2860
22423
1.61
59.77
7.4
6.3
umol/l
11.2
11.9
2.42
2744
21325
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1895
13446
1.64
59.72
3.2
2.6
u/l
57.0
58.6
0.51
1757
12461
(3019069) Monocytes/100 leukocytes in Blood
2622
20138
1.61
59.68
9.5
6.3
%
8.7
8.8
0.82
2479
18842
(3020891) Body temperature
417
1784
2.45
59.45
6.4
4.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2659
20535
1.60
58.80
6.3
4.8
estimate
0.0
0.0
0.50
481
3903
(3006504) Eosinophils/100 leukocytes in Blood
2605
20026
1.60
58.68
9.1
6.0
%
2.9
2.9
0.41
2454
18651
(3009261) Glucose [Presence] in Urine by Test strip
2683
20794
1.60
58.22
5.2
3.6
estimate
0.0
0.0
1.72
461
3740
(3022096) Basophils/100 leukocytes in Blood
2541
19470
1.59
57.66
9.1
6.0
%
0.7
0.7
0.85
2395
18157
(3031040) Bacteria [#/volume] in Urine by Automated count
3383
27745
1.62
57.63
5.6
4.4
e6/l
312.2
1477.2
2.07
50
409
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1865
13270
1.63
57.59
2.5
2.2
u/l
232.7
230.5
0.02
1761
12457
(3018010) Neutrophils/100 leukocytes in Blood
2629
20353
1.59
56.74
8.8
5.9
%
57.8
57.5
0.60
2482
19018
(3002030) Lymphocytes/100 leukocytes in Blood
2661
20659
1.59
56.74
9.3
6.1
%
27.2
27.5
0.47
2501
19219
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2246
16808
1.59
55.68
2.7
2.2
nmol/l
77.1
77.1
0.00
2033
15049
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1127
7151
1.73
53.15
2.1
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2119
15811
1.57
52.14
5.5
3.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1559
10840
1.62
51.57
2.6
2.2
mg/l
3.1
2.9
1.56
1355
9273
(3019060) Gas panel - Arterial blood
578
3002
2.04
51.01
5.0
4.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
3131
25582
1.56
50.82
6.2
4.8
mmol/l
6.9
6.8
1.36
2954
24038
(3037467) Urinalysis macro (dipstick) panel - Urine
3481
29174
1.58
50.17
5.6
4.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1652
11724
1.60
49.85
3.5
2.7
umol/l
4124.8
5114.8
0.43
1440
10166
(3008152) Bicarbonate [Moles/volume] in Arterial blood
548
2843
2.04
48.40
7.9
6.9
mmol/l
24.6
24.5
0.18
508
2655
(3037522) Nuclear Ab [Titer] in Serum
896
5465
1.77
48.01
1.4
1.3
titre
493.2
502.1
0.05
197
1102
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4679
42559
1.96
47.59
22.6
14.7
mg/l
25.0
24.9
0.14
4020
33970
(3018418) pH of Serum or Plasma
1744
12658
1.57
47.18
5.7
4.1
ph
7.4
7.4
0.33
317
2436
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1749
12750
1.56
46.17
3.7
3.1
ng/l
1609.4
1515.2
0.33
1517
10972
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
820
4941
1.78
45.60
2.0
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
687
3929
1.86
45.34
2.6
2.3
ug/l
5.5
7.9
3.37
600
3461
(3003396) Base excess in Arterial blood by calculation
855
5225
1.76
45.27
6.5
7.4
mmol/l
1.2
1.0
0.57
678
4050
(3027801) Oxygen [Partial pressure] in Arterial blood
854
5238
1.75
44.58
6.5
7.4
kpa
11.6
12.4
3.36
819
5001
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
854
5239
1.75
44.55
6.5
7.4
kpa
5.1
5.1
0.28
818
5004
(3016502) Oxygen saturation in Arterial blood
784
4696
1.79
44.40
6.6
7.8
%
95.2
95.6
1.29
756
4526
(3026008) Bacteria identified in Urine by Culture
1671
12170
1.55
43.75
3.7
3.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
903
5673
1.72
43.13
7.2
7.1
mmol/l
103.8
104.5
3.66
878
5547
(42870588) Differential panel, method unspecified - Blood
1948
14705
1.52
43.03
8.4
5.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
924
5853
1.70
42.78
8.6
6.1
mmol/l
1.1
1.0
1.62
860
5455
(3014111) Lactate [Moles/volume] in Serum or Plasma
683
3969
1.83
42.66
5.9
7.3
mmol/l
1.4
1.4
0.49
664
3820
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
806
4932
1.75
42.23
1.9
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
563
3094
1.92
41.85
1.7
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2145
16629
1.49
41.09
4.5
3.7
ng/l
41.1
81.5
0.85
1607
11722
(3043409) Potassium [Moles/volume] in Arterial blood
305
1341
2.35
40.64
5.1
4.1
mmol/l
3.9
3.9
0.43
288
1252
(3032080) INR in Blood by Coagulation assay
2295
18064
1.48
40.60
12.0
9.6
inr
1.3
1.3
0.22
611
5147
(3015377) Calcium [Moles/volume] in Serum or Plasma
1881
14233
1.50
40.38
3.6
3.4
mmol/l
2.3
2.4
0.83
1647
12422
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
118
306
3.92
40.14
1.7
1.5
u/ml
18.1
21.2
0.36
21
58
(3022948) Iron [Moles/volume] in Serum or Plasma
1035
6883
1.63
39.34
3.3
2.5
umol/l
12.4
13.1
2.13
961
6411
(3000850) Epithelial cells [#/volume] in Urine
1318
9288
1.56
39.16
3.3
2.6
e6/l
4.6
4.9
0.38
1210
8117
(3010375) cycloSPORINE [Mass/volume] in Blood
86
178
4.90
39.04
27.6
25.6
ug/l
100.4
116.1
1.45
68
141
(3002173) Hemoglobin [Mass/volume] in Arterial blood
715
4320
1.76
38.93
7.0
8.2
g/l
121.9
121.9
0.02
688
4165
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2212
17453
1.46
37.71
3.5
2.8
ug/l
144.9
144.1
0.05
2057
16133
(3000991) Gas panel - Venous blood
642
3794
1.79
37.64
7.5
8.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3622
31465
1.49
37.11
4.5
3.8
pmol/l
14.9
14.8
1.29
3324
28541
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1299
9227
1.54
36.87
1.9
1.8
mg/l
1.3
1.3
0.07
1003
7073
(3015171) Extractable nuclear Ab [Units/volume] in Serum
319
1494
2.21
36.55
1.3
1.2
u/ml
0.5
1.0
1.05
35
131
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
217
858
2.60
36.34
7.6
5.3
iu/ml
921.3
2422.1
0.38
36
123
(3019309) Folate [Moles/volume] in Red Blood Cells
1162
8074
1.56
36.33
1.8
1.8
nmol/l
1287.4
1160.1
3.47
900
6089
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2213
17583
1.45
35.73
2.2
2.0
pmol/l
93.1
94.4
0.58
1243
9326
(3009445) Proteinase 3 Ab [Units/volume] in Serum
370
1860
2.06
35.29
1.8
1.5
u/ml
11.0
19.7
0.84
14
46
(3005719) IgG [Mass/volume] in Serum or Plasma
552
3204
1.81
34.22
3.3
2.6
g/l
10.4
10.6
0.64
516
2915
(40758558) Short blood count panel - Blood
1464
10842
1.49
33.49
8.5
6.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
4727
43967
1.80
33.13
24.7
17.1
mmol/l
139.4
139.7
7.54
4646
42895
(3004789) Transferrin [Mass/volume] in Serum or Plasma
945
6388
1.59
32.90
3.3
2.5
g/l
2.3
2.3
0.15
877
5947
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1205
8611
1.52
32.64
1.4
1.3
u/ml
2.3
1.9
0.33
351
2246
(3027945) Reticulocytes/100 erythrocytes in Blood
784
5080
1.64
32.47
3.4
2.5
%
1.8
1.8
0.42
690
4497
(3023103) Potassium [Moles/volume] in Serum or Plasma
4734
44092
1.79
32.46
24.8
17.2
mmol/l
4.0
4.0
5.80
4645
42954
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
177
669
2.70
32.45
3.4
2.8
u/ml
701.7
2793.5
—
7
44
(3017181) Myelocytes/100 leukocytes in Blood
607
3678
1.74
32.37
5.5
4.1
%
1.0
0.9
0.34
217
1071
(3021960) Folate [Moles/volume] in Serum or Plasma
1362
10001
1.49
32.29
1.7
1.5
nmol/l
19.5
20.2
0.74
1187
8564
(3021447) Carbon dioxide [Partial pressure] in Venous blood
674
4227
1.68
31.63
4.9
3.8
kpa
5.9
5.8
1.06
652
4098
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1033
7186
1.55
31.55
4.5
3.4
mmol/l
0.8
0.8
1.16
973
6722
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4226
38331
1.54
31.54
5.4
4.5
mu/l
1.9
2.1
1.27
3903
34970
(3024354) Oxygen [Partial pressure] in Venous blood
574
3452
1.74
31.39
4.3
3.2
kpa
4.6
4.7
0.07
551
3337
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
794
5202
1.62
31.37
4.7
4.3
u/l
255.2
243.0
0.73
754
4930
(3026389) Candida sp identified in Specimen by Organism specific culture
141
482
2.98
31.16
1.4
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
670
4214
1.68
31.07
4.9
3.9
mmol/l
1.9
1.9
0.13
550
3400
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
176
683
2.63
30.63
1.6
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1790
13968
1.43
30.45
3.8
3.2
mmol/l
7.3
7.8
4.27
1547
11737
(3017143) Hepatitis C virus Ab [Presence] in Serum
712
4580
1.64
30.20
1.9
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
393
2130
1.91
30.15
4.2
3.4
mmol/l
25.1
25.2
0.22
384
2060
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
355
1861
1.97
30.05
2.3
1.9
ug/l
2.8
2.8
0.02
319
1651
(3012516) Albumin [Mass/volume] in Urine
1704
13215
1.43
29.85
3.8
3.3
mg/l
602.5
380.2
0.93
1200
8562
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
265
1254
2.17
29.55
1.5
1.6
iu/ml
2.3
8.0
0.54
54
272
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
298
1476
2.08
29.52
1.8
1.6
titre
105.5
293.3
1.69
11
63
(3012544) pH of Venous blood
683
4389
1.64
29.01
4.9
3.9
ph
7.4
7.4
—
6
23
(3002179) Metamyelocytes/100 leukocytes in Blood
551
3350
1.72
28.88
5.1
3.9
%
0.6
0.6
0.17
157
770
(3020630) Protein [Mass/volume] in Serum or Plasma
600
3743
1.68
28.57
2.6
2.6
g/l
65.9
66.4
0.88
551
3405
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
372
2026
1.90
28.09
4.0
2.7
%
0.7
0.6
1.81
354
1942
(36304419) Bacteria [Presence] in Urine
1541
11866
1.42
27.60
3.9
3.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
74
181
4.13
27.35
41.9
33.8
ug/l
7.3
7.4
0.25
68
163
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
869
5988
1.54
27.29
3.5
2.6
%
21.3
23.1
4.00
743
5134
(3020682) Albumin/Creatinine [Ratio] in Urine
1762
13915
1.40
27.22
4.5
4.0
mg/mmol
11.9
9.7
0.83
1223
8993
(3028026) IgM [Mass/volume] in Serum or Plasma
436
2522
1.80
27.13
2.0
1.9
g/l
1.3
1.4
0.03
393
2291
(3023520) Reticulocytes [#/volume] in Blood
600
3796
1.66
26.99
3.0
2.6
e9/l
71.7
69.6
0.60
466
2884
(3048689) Calprotectin [Mass/mass] in Stool
716
4739
1.59
26.80
2.6
2.3
ug/g
170.7
147.5
0.60
588
3740
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
375
2080
1.87
26.74
4.0
2.8
%
1.3
1.2
1.76
375
2066
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4810
45369
1.77
26.66
15.2
10.5
u/l
26.7
27.2
0.93
4686
43735
(3030467) Casts [#/volume] in Urine by Automated count
1573
12232
1.41
26.40
4.0
3.2
e6/l
0.4
0.4
0.19
1296
9196
(3018095) Leukocytes [#/volume] in Urine
1910
15353
1.38
26.31
4.5
3.8
e6/l
106.6
93.6
0.20
1495
11006
(3020779) Urea [Moles/volume] in Serum or Plasma
646
4193
1.62
26.20
11.0
7.6
mmol/l
10.6
10.1
0.96
615
3997
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
518
3189
1.69
25.82
5.5
4.0
ng/l
112.2
93.8
2.79
465
2763
(3036481) Cortisol [Moles/volume] in Serum or Plasma
592
3775
1.64
25.76
2.9
2.2
nmol/l
327.8
371.4
6.55
548
3464
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
89
260
3.47
25.54
1.4
1.3
titre
110.9
73.0
0.71
11
23
(3021440) Promyelocytes/100 leukocytes in Blood
557
3505
1.66
25.53
5.6
4.1
%
0.1
0.2
1.22
183
1004
(3007164) IgA [Mass/volume] in Serum or Plasma
1059
7700
1.47
25.47
1.6
1.5
g/l
2.5
2.5
0.07
686
4686
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
91
271
3.40
25.35
1.4
1.3
titre
951.4
212.7
—
7
22
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
249
1223
2.09
25.22
1.9
1.5
g/l
1.2
1.2
0.18
239
1159
(46235355) HIV 1 and 2 tests - Meaningful Use set
924
6554
1.50
25.11
1.9
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
289
1507
1.97
24.80
2.7
2.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4269
39325
1.47
24.48
7.2
5.9
mmol/mol
41.2
40.1
9.64
4000
36381
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2385
20013
1.35
24.46
4.8
4.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
246
1217
2.07
24.44
1.9
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1057
7752
1.46
24.15
3.1
3.1
mmol/l
2.5
2.5
0.13
933
6795
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
945
6787
1.48
24.03
1.3
1.3
iu/ml
40.4
33.5
0.56
296
2088
(3005322) IgE [Units/volume] in Serum or Plasma
413
2451
1.74
23.46
1.4
1.3
u/ml
561.5
222.1
1.95
383
2245
(40761511) CBC panel - Blood by Automated count
4686
44135
1.60
23.09
20.2
13.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
219
1065
2.10
22.78
1.8
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
492
3089
1.65
22.65
2.2
2.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1737
14001
1.36
22.60
4.0
3.2
u/l
33.9
36.0
0.50
1647
13279
(3025941) Bacteria identified in Stool by Culture
380
2229
1.76
22.47
1.4
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
246
1259
2.00
22.27
1.3
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
515
3287
1.63
22.20
5.6
4.1
%
0.2
0.3
0.28
161
834
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
234
1178
2.03
22.18
2.0
1.5
g/l
0.2
0.2
2.25
225
1112
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
211
1032
2.09
21.63
1.8
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
419
2555
1.70
21.54
1.8
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
441
2726
1.67
21.53
4.1
3.3
g/l
129.3
129.4
0.02
432
2650
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
171
777
2.24
21.12
1.9
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
89
293
3.07
21.11
2.4
2.4
e6/l
651.3
660.0
0.03
23
122
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1011
7530
1.42
20.88
3.3
2.8
e6/l
1.3
1.1
0.65
702
4297
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
611
4120
1.55
20.78
2.3
2.3
g/l
0.2
0.2
0.67
556
3837
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
882
6412
1.45
20.77
1.3
1.2
u/ml
11.0
11.4
0.05
360
2457
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
772
5475
1.48
20.64
1.7
1.6
—
—
—
0
0
(4010399)
473
3014
1.63
20.48
1.5
1.4
—
—
—
0
0
(44790049)
124
495
2.54
20.47
1.8
1.4
—
—
—
0
0
(44790047)
124
495
2.54
20.47
1.8
1.4
—
—
—
0
0
(44806118)
124
495
2.54
20.47
1.8
1.4
—
—
—
0
0
(44790048)
124
495
2.54
20.47
1.8
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
118
460
2.60
20.45
1.8
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
113
432
2.65
20.37
1.8
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2030
16949
1.32
20.21
2.4
2.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
77
239
3.26
20.16
3.0
2.7
%
38.4
37.8
0.07
18
84
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
142
610
2.37
20.01
1.8
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
231
1202
1.96
19.96
1.5
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
828
5999
1.45
19.76
35.0
25.7
inr
1.4
1.4
0.37
110
871
(3002582) Erythrocytes [#/volume] in Urine
1645
13384
1.33
19.40
4.1
3.3
e6/l
87.2
87.0
0.00
1363
10292
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
178
856
2.12
19.10
1.4
1.2
titre
73.3
203.0
—
6
20
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
102
385
2.68
18.88
1.8
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
102
385
2.68
18.88
1.8
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
102
385
2.68
18.88
1.8
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4467
41978
1.45
18.73
5.3
4.5
mmol/l
4.5
4.6
10.41
4160
38891
(3021589) Normoblasts [#/volume] in Blood
2222
18923
1.30
18.67
12.9
9.7
e9/l
0.0
0.0
0.42
1894
15443
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4438
41670
1.43
18.56
5.1
4.4
mmol/l
1.4
1.4
0.87
4102
38373
(3000963) Hemoglobin [Mass/volume] in Blood
4923
47271
1.73
18.53
32.9
21.6
g/l
134.6
136.3
11.87
4869
46591
(3024731) MCV [Entitic volume]
4921
47256
1.72
18.39
32.6
21.4
fl
91.4
91.1
4.90
4870
46573
(3026361) Erythrocytes [#/volume] in Blood
4921
47260
1.72
18.33
32.7
21.5
e12/l
4.5
4.5
10.38
4832
45892
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4394
41204
1.42
18.31
5.3
4.6
mmol/l
6.1
6.0
5.08
4036
37524
(3007461) Platelets [#/volume] in Blood
4919
47237
1.72
18.31
32.7
21.5
e9/l
245.9
246.1
0.09
4844
46002
(3035941) MCH [Entitic mass]
4920
47253
1.72
18.25
32.5
21.4
pg
30.4
30.4
0.27
4868
46569
(3010813) Leukocytes [#/volume] in Blood
4921
47269
1.72
18.20
32.8
21.5
e9/l
7.0
6.8
5.42
4835
45893
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4306
40281
1.39
17.82
4.7
4.0
mmol/l
1.4
1.3
3.06
3976
36848
(3044889) 12 lead EKG panel
3364
30358
1.30
17.80
4.7
3.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
275
1573
1.79
17.71
2.7
2.3
ug/l
556.5
597.3
0.08
258
1493
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
445
2903
1.58
17.41
5.0
3.6
kpa
5.2
5.1
1.09
415
2680
(3009343) pH of Capillary blood
439
2862
1.58
17.22
5.0
3.6
ph
7.4
7.4
1.75
59
344
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
426
2758
1.59
17.21
4.9
3.6
mmol/l
1.8
1.7
0.24
331
2016
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4529
42806
1.44
17.10
5.7
5.0
mmol/l
2.6
2.7
13.10
4193
39413
(3020961) Endomysium IgA Ab [Titer] in Serum
300
1786
1.72
16.81
1.2
1.1
titre
106.4
191.8
—
7
46
(3021879) Hepatitis B virus core Ab [Presence] in Serum
451
2978
1.56
16.73
1.6
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
158
765
2.10
16.70
1.6
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
155
747
2.11
16.59
1.8
1.5
u/ml
104.8
120.4
0.93
47
144
(3000570) Elastase.pancreatic [Mass/mass] in Stool
225
1237
1.86
16.50
1.6
1.4
ug/g
254.9
272.6
0.66
144
723
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
340
2108
1.66
16.36
1.9
1.7
g/l
1.5
1.5
0.00
290
1816
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
132
607
2.21
15.92
1.6
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
166
838
2.01
15.69
1.8
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
167
846
2.01
15.64
4.2
3.6
%
57.5
57.9
0.12
167
846
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
96
388
2.50
15.54
1.2
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
28
49
5.74
15.37
2.1
1.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
196
1055
1.89
15.37
1.7
1.6
e6/l
9528.2
12948.8
0.78
153
758
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2869
25619
1.27
15.23
3.0
2.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
98
404
2.45
15.22
1.7
1.5
%
29.6
30.0
0.03
70
249
(3018677) aPTT in Platelet poor plasma by Coagulation assay
913
7028
1.36
14.96
2.4
2.1
s
30.0
30.0
0.02
885
6837
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
208
1154
1.84
14.84
1.4
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
48
135
3.58
14.73
3.1
3.9
mg/l
6.8
7.9
0.59
40
115
(3015235) Bicarbonate [Moles/volume] in Capillary blood
209
1165
1.83
14.69
4.2
3.3
mmol/l
25.3
24.7
1.04
188
1002
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
169
881
1.95
14.60
1.7
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
77
289
2.69
14.50
2.5
2.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
208
1165
1.82
14.40
1.4
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1134
9078
1.32
14.17
1.7
1.7
pmol/l
37785113.7
28184165.7
0.22
966
7554
(3011412) CD3 cells [#/volume] in Blood
94
394
2.41
14.11
2.4
2.4
e9/l
1.1
1.2
0.45
67
230
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
193
1064
1.85
14.07
2.0
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
208
1174
1.80
14.05
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
186
1017
1.86
13.92
1.4
1.2
u/ml
4.0
7.6
1.16
24
160
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
152
778
1.98
13.87
1.4
1.2
u/ml
268.3
267.4
0.01
92
485
(3042733) HLA Ab [Presence] in Serum
47
136
3.48
13.84
5.7
4.9
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
127
611
2.11
13.72
7.0
6.8
mg/l
11.7
11.7
0.01
120
566
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3103
28140
1.25
13.68
3.8
3.1
u/l
57.3
51.4
1.97
2893
26174
(3037692) Legionella sp identified in Specimen by Organism specific culture
49
147
3.36
13.65
1.8
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
159
832
1.94
13.61
1.4
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
183
1003
1.85
13.60
1.4
1.2
u/ml
3.5
6.1
0.29
17
94
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
42
114
3.71
13.59
2.1
1.4
ug/l
9.5
8.8
0.44
42
114
(3003327) Ova and parasites identified in Stool by Light microscopy
215
1239
1.77
13.55
1.7
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
263
1608
1.67
13.38
3.6
3.2
u/ml
0.3
0.3
0.37
164
911
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
46
135
3.43
13.27
2.8
2.1
ug/l
61.7
60.6
0.03
46
130
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
61
4.78
13.05
5.0
6.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
103
467
2.23
12.94
1.1
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
95
417
2.30
12.88
1.3
1.4
e6/l
161687.7
93332.3
0.29
66
298
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
93
405
2.32
12.85
2.1
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
112
527
2.15
12.84
2.4
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1271
10448
1.29
12.83
2.9
2.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
153
807
1.92
12.82
1.3
1.2
u/ml
3.2
5.5
—
6
59
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
172
947
1.84
12.63
1.4
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
190
1079
1.79
12.61
1.4
1.2
u/ml
9.8
36.2
—
6
55
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
110
528
2.11
12.00
1.7
1.6
%
57.3
60.4
0.31
70
332
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
107
509
2.13
11.95
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
132
681
1.96
11.83
1.5
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
120
599
2.03
11.80
1.5
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
82
353
2.34
11.67
2.0
2.2
%
37.3
43.3
—
6
43
(3002385) Erythrocyte distribution width [Ratio]
3760
35118
1.25
11.56
24.4
17.9
%
13.9
13.7
13.51
3696
34353
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
76
319
2.40
11.45
2.1
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
331
2225
1.52
11.31
5.3
4.1
mmol/l
23.9
24.1
0.77
265
2015
(3004716) Salmonella sp identified in Stool by Organism specific culture
290
1901
1.56
11.11
1.5
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
188
1119
1.71
10.64
2.0
1.9
mg/l
11.5
11.2
0.15
175
1033
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
192
1152
1.69
10.55
2.5
2.3
ug/min
203.2
121.7
0.82
117
706
(3001964) Herpes simplex virus Ag [Presence] in Specimen
39
121
3.24
10.38
1.7
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
71
304
2.35
10.27
2.3
2.1
%
14.5
13.6
0.16
31
132
(3048929) Epstein Barr virus Ab [Presence] in Serum
197
1199
1.67
10.27
1.4
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
274
1806
1.55
10.26
2.1
1.9
u/l
39.1
38.7
0.11
242
1585
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
359
2509
1.46
10.14
8.4
10.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
196
1197
1.66
10.09
1.4
1.4
iu/ml
13.3
18.0
—
7
26
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
49
177
2.79
10.04
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1580
13638
1.23
9.95
3.0
2.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
180
1082
1.69
9.85
4.3
3.1
kpa
8.2
8.2
0.22
170
993
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
815
6523
1.30
9.84
1.5
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3819
35944
1.23
9.83
29.6
18.8
g/l
332.1
332.9
5.81
3791
35663
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
193
1188
1.65
9.65
5.3
3.4
mg/l
1.7
1.5
1.45
180
1093
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
138
777
1.80
9.52
1.4
1.2
u/ml
54.3
41.2
0.48
18
78
(40757373) Influenza virus identified in Isolate
32
93
3.46
9.45
1.8
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
338
2378
1.45
9.23
3.2
3.3
pmol/l
4.4
4.5
1.22
288
2098
(3008757) Leukocyte morphology finding [Identifier] in Blood
95
479
2.00
9.18
4.8
4.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
145
842
1.74
9.02
3.6
2.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
386
2799
1.41
8.94
2.4
2.4
au/ml
36.4
23.5
1.04
20
133
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
208
1331
1.59
8.91
2.0
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
105
557
1.90
8.78
1.4
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
157
941
1.69
8.73
1.5
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
1039
8687
1.24
8.63
3.6
2.8
mosm/kgh2o
527.2
557.8
5.08
927
7399
(3000093) Morphology [Interpretation] in Blood Narrative
87
435
2.02
8.63
1.2
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
51
204
2.51
8.61
5.5
3.3
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
40
142
2.83
8.51
1.5
1.3
%
61.3
55.3
0.47
35
122
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
159
963
1.67
8.51
1.7
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
299
2090
1.46
8.47
5.2
3.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
134
778
1.74
8.37
1.5
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
201
1296
1.57
8.35
2.6
2.8
g/l
3.5
3.6
0.10
187
1234
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
341
2449
1.42
8.35
7.3
9.7
mmol/l
24.2
24.2
0.05
304
2296
(3035947) Staphylolysin Ab [Units/volume] in Serum
53
220
2.42
8.29
1.3
1.1
iu/ml
4.7
3.9
—
6
11
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
62
276
2.26
8.28
2.6
2.5
e6/l
512.9
527.0
0.08
54
229
(3004809) Band form neutrophils/100 leukocytes in Blood
130
751
1.75
8.27
4.5
3.4
%
1.1
1.7
1.33
103
569
(3022145) Colonoscopy Study observation
604
4754
1.31
8.20
1.4
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
38
134
2.85
8.20
1.9
2.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
50
204
2.47
8.12
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
393
2913
1.38
8.00
3.6
3.0
e9/l
4.3
4.1
0.43
293
2270
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
115
649
1.79
7.94
1.2
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
248
1693
1.49
7.94
2.0
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4192
40101
1.23
7.92
18.4
13.9
ml/min/173m2
79.1
80.2
2.21
3580
33224
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
101
549
1.86
7.88
1.4
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
159
984
1.64
7.85
2.6
2.8
umol/l
31.7
35.1
1.10
135
836
(3037121) Protein [Mass/volume] in Urine
226
1523
1.51
7.71
4.5
3.1
g/l
0.2
0.3
1.19
117
657
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
80
405
1.99
7.71
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
101
553
1.84
7.71
1.4
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
387
2882
1.37
7.66
1.8
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
37
134
2.77
7.62
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
157
977
1.63
7.60
1.6
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
38
140
2.73
7.59
1.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
577
4562
1.30
7.57
4.2
3.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
347
2546
1.39
7.52
1.3
1.3
au/ml
64.5
54.1
0.24
14
117
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
82
423
1.95
7.50
2.4
2.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
99
545
1.83
7.44
1.4
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
37
137
2.71
7.33
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
58
267
2.19
7.20
1.2
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
55
248
2.23
7.18
1.6
1.4
u/l
5.8
6.9
0.57
44
212
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1017
8635
1.22
7.17
4.7
3.8
ng/l
345.3
562.1
0.98
795
6917
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
642
5181
1.27
7.16
2.1
1.8
%
1.6
1.5
1.40
553
4545
(3013139) Helicobacter pylori Ag [Presence] in Stool
357
2657
1.37
7.10
1.3
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
35
128
2.75
7.10
1.1
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
613
4926
1.28
7.07
3.4
2.8
umol/l
9.3
8.8
0.21
530
4323
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
98
547
1.81
7.06
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
98
549
1.80
6.98
1.4
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
110
638
1.74
6.97
4.8
5.0
umol/l
347.3
359.0
0.36
99
552
(3016650) Hepatitis A virus Ab [Presence] in Serum
116
684
1.71
6.93
1.1
1.1
—
—
—
0
0
(44813793)
55
252
2.20
6.92
1.0
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
81
429
1.90
6.89
1.2
1.2
u/l
68.9
63.7
0.17
62
281
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
54
246
2.21
6.89
1.4
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
272
1944
1.42
6.89
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
261
1852
1.43
6.88
2.3
1.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
128
777
1.66
6.87
1.3
1.3
mmol/l
62.9
63.6
0.06
100
628
(21494755) Public health laboratory ask at order entry panel
266
3675
0.71
6.86
1.3
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
114
675
1.70
6.72
1.6
1.6
g/l
0.7
0.9
1.35
93
515
(3047181) Lactate [Moles/volume] in Blood
208
1421
1.48
6.69
6.2
6.3
mmol/l
1.4
1.3
0.73
183
1257
(3028433) Virus identified in Specimen by Culture
35
133
2.64
6.63
1.3
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
370
2802
1.34
6.60
7.3
7.4
mmol/l
24.8
24.8
0.02
365
2785
(40768797) Stomach Pathology biopsy report
709
5845
1.25
6.57
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
145
919
1.59
6.57
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
145
919
1.59
6.57
1.4
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
53
245
2.18
6.55
1.4
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
254
1811
1.42
6.53
5.5
3.8
mmol/l
24.8
24.8
0.00
237
1671
(1616796) Gas panel - Central venous blood
156
1008
1.56
6.51
5.0
3.9
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
15
33
4.56
6.45
1.8
2.0
mg/l
2.0
1.7
—
9
27
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2004
18196
1.16
6.43
4.6
5.0
ug/l
3.2
3.4
0.13
1796
16366
(3004616) Nuclear Ab [Presence] in Serum
88
493
1.80
6.31
1.4
1.2
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
33
125
2.65
6.30
1.7
2.0
mg/l
7.9
8.7
0.45
24
105
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
18
47
3.84
6.25
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
40
168
2.39
6.19
2.5
2.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
231
1641
1.43
6.09
2.4
2.3
g/l
3.1
3.1
0.10
173
1277
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
147
953
1.56
6.07
2.5
2.2
u/l
1567.4
4160.2
1.37
42
365
(3042631) Mycobacterium sp identified in Specimen
103
614
1.69
5.97
2.4
2.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
113
692
1.65
5.92
1.5
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
403
3142
1.31
5.88
1.2
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
39
166
2.36
5.87
2.2
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
54
264
2.06
5.82
1.7
1.6
u/l
6.4
6.5
0.01
32
121
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
15
36
4.18
5.81
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
45
205
2.21
5.80
1.6
1.4
%
0.9
3.9
1.85
12
45
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
34
138
2.47
5.68
1.3
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
151
1003
1.52
5.62
2.9
2.2
g/l
129.3
130.2
0.15
110
721
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
177
1218
1.47
5.55
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
345
2656
1.32
5.53
1.9
1.7
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
76
426
1.80
5.49
1.2
1.3
nmol/l
1.4
1.5
0.17
71
378
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1616
14568
1.16
5.49
4.4
4.3
%
22.8
21.9
1.35
801
7148
(21494814) CD8 cells/100 lymphocytes in Specimen
38
166
2.30
5.43
1.8
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
77
436
1.78
5.39
2.8
3.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
85
497
1.72
5.33
1.8
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
141
938
1.52
5.24
2.4
1.9
nmol/l
0.8
0.8
0.13
122
783
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
477
3862
1.26
5.18
3.4
2.9
ng/l
213.9
205.7
0.17
442
3505
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
39
176
2.23
5.18
2.4
1.8
umol/l
157.7
143.6
0.11
21
101
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
200
1428
1.42
5.18
3.2
3.4
mg/l
37.6
59.4
1.28
160
1162
(3003434) Protein [Mass/volume] in Pleural fluid
104
647
1.62
5.17
1.4
1.5
g/l
31.5
32.7
0.40
91
582
(3034860) Kappa light chains.free [Mass/volume] in Serum
200
1429
1.42
5.16
3.2
3.4
mg/l
43.0
98.9
0.79
162
1159
(3028192) IgG subclass 2 [Mass/volume] in Serum
74
420
1.77
5.16
1.6
1.4
g/l
3.2
2.9
0.68
55
295
(3024139) IgG subclass 3 [Mass/volume] in Serum
74
420
1.77
5.16
1.6
1.4
g/l
0.5
0.4
0.98
56
294
(3027135) IgG subclass 1 [Mass/volume] in Serum
74
420
1.77
5.16
1.6
1.4
g/l
6.5
6.8
0.27
56
296
(3021788) Differential panel - Synovial fluid
122
789
1.56
5.16
1.7
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
24
86
2.80
5.13
1.1
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
196
1397
1.42
5.13
3.2
3.3
ratio
1.6
2.7
0.90
17
114
(4062490)
74
422
1.76
5.08
1.6
1.4
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
31
128
2.43
5.03
1.1
1.6
pmol/l
15.0
15.5
0.21
25
110
(3030981) Hyaline casts [#/volume] in Urine by Automated count
307
2359
1.32
5.02
2.8
2.8
e6/l
0.4
0.3
0.31
300
2303
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
190
1353
1.42
5.00
2.4
2.1
g/l
37.3
37.7
0.45
165
1162
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
51
260
1.97
4.96
1.2
1.3
u/ml
0.5
0.7
0.12
22
122
(4034850)
192
1373
1.41
4.94
12.9
9.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
237
1757
1.37
4.92
2.4
2.3
g/l
3.8
3.8
0.36
173
1247
(3002619) Bacteria identified in Specimen by Culture
22
77
2.87
4.91
1.6
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
237
1758
1.36
4.91
2.4
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
237
1759
1.36
4.89
2.4
2.3
g/l
7.5
7.4
0.30
177
1302
(3017354) Segmented neutrophils/100 leukocytes in Blood
80
472
1.71
4.89
4.2
3.5
%
61.3
57.7
0.91
52
292
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
75
437
1.73
4.80
1.5
1.4
u/l
23.8
26.8
0.38
61
359
(40765096) Chromosome analysis panel by Banding
33
144
2.30
4.76
1.3
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
171
1207
1.43
4.75
2.6
2.2
g/l
0.0
0.0
0.00
156
1101
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
48
244
1.98
4.72
1.2
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
93
577
1.62
4.71
1.5
1.4
e6/l
1847.2
1998.7
0.09
65
419
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
38
177
2.16
4.70
2.1
2.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
153
1061
1.46
4.67
1.4
1.4
mg/l
525.8
537.2
0.08
147
999
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
67
382
1.76
4.64
1.7
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
25
97
2.58
4.63
1.2
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
168
1191
1.42
4.57
2.6
2.2
g/l
0.0
0.0
0.00
155
1100
(3034770) Mitochondria Ab [Titer] in Serum
165
1166
1.43
4.57
1.2
1.2
titre
1721.3
926.4
—
8
33
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
290
2242
1.31
4.56
2.5
2.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
181
1302
1.40
4.54
2.5
2.2
g/l
0.0
0.0
1.04
166
1192
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
74
437
1.70
4.54
1.1
1.1
—
3.3
—
0
5
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
203
1489
1.38
4.53
2.6
2.4
g/l
0.7
1.0
0.71
177
1275
(21494890) Protein electrophoresis panel - 24 hour Urine
79
475
1.67
4.53
2.4
2.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
22
81
2.72
4.50
1.1
1.8
ug/l
1.5
2.1
0.80
13
43
(3013512) EKG study
1401
12652
1.15
4.48
4.5
4.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
533
4440
1.22
4.48
1.6
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
219
1633
1.36
4.42
2.4
2.3
g/l
10.1
10.2
0.18
177
1377
(3039000) Anion gap in Blood
147
1024
1.45
4.41
7.1
7.2
mmol/l
11.5
11.3
0.23
132
921
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
248
1886
1.33
4.39
5.4
5.2
%
1.8
1.7
0.78
232
1768
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
136
934
1.47
4.39
1.4
1.3
mmol/l
3.7
3.8
0.95
126
872
(3018572) Chloride [Moles/volume] in Blood
147
1025
1.45
4.39
7.1
7.2
mmol/l
105.1
105.1
0.08
132
922
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
183
1328
1.39
4.37
2.5
2.5
%
90.6
89.9
0.14
173
1256
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
37
176
2.11
4.37
2.1
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
37
176
2.11
4.37
2.1
2.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
84
519
1.63
4.35
1.4
1.4
e6/l
67172.5
70924.2
0.04
46
306
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
34
157
2.17
4.32
1.1
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
278
3554
0.77
4.32
1.7
1.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
163
1166
1.41
4.24
1.2
1.2
titre
104.2
91.5
0.33
12
97
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
16
51
3.14
4.20
1.2
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
37
179
2.07
4.20
1.7
1.5
umol/l
29.8
29.0
0.23
37
172
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1254
11285
1.15
4.18
1.9
1.6
mmol/l
1.4
1.4
1.74
1073
9482
(1761868) Lipid panel - Serum or Plasma
1342
14782
0.88
4.17
3.0
2.9
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
11
27
4.08
4.16
1.2
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
74
449
1.66
4.14
1.4
1.5
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
38
187
2.04
4.13
2.4
5.8
mg/l
59.1
70.9
0.77
28
131
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
149
1055
1.42
4.12
1.4
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
88
559
1.58
4.10
1.5
1.4
mu/l
48.3
59.2
0.35
79
497
(3041096) Erythrocytes [Presence] in Urine by Automated
1232
11088
1.15
4.09
4.4
3.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
431
3546
1.23
4.09
4.9
4.0
mmol/l
1.2
1.2
0.03
392
3124
(3035637) Corticotropin [Mass/volume] in Plasma
83
521
1.60
4.06
1.7
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
472
3930
1.22
4.00
2.3
2.2
nmol/l
13.2
12.9
0.28
423
3469
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
14
6.44
3.98
2.4
2.8
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
18
64
2.82
3.95
1.5
1.2
ng/l
40.0
62.7
—
10
45
(3008898) HLA-B27 [Presence]
174
1277
1.38
3.92
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
34
164
2.08
3.91
1.3
1.1
miu/ml
1648.9
1550.5
0.19
34
164
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
144
1024
1.42
3.91
1.3
1.3
miu/ml
157.9
206.4
0.86
53
443
(40760888) Immunoglobulin light chains.free panel - Serum
151
1085
1.40
3.87
3.5
3.5
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
8
11
7.28
3.85
4.3
5.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
73
451
1.63
3.83
1.4
1.3
u/l
391.4
345.0
0.24
67
433
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
58
338
1.72
3.79
1.5
1.3
mmol/l
3.1
2.0
0.95
53
318
(3009542) Hematocrit [Volume Fraction] of Blood
3993
38682
1.14
3.76
21.0
15.7
%
39.7
39.9
0.95
2533
27448
(3008295) Osmolality of Serum or Plasma
75
469
1.61
3.76
1.5
1.4
mosm/kgh2o
281.7
280.3
0.19
59
361
(40767503) Oxygen content in Capillary blood by calculation
139
991
1.41
3.73
3.8
2.5
%
16.3
16.3
0.10
85
499
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
27
121
2.24
3.73
1.1
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
19
72
2.64
3.72
1.2
1.8
ng/l
104.1
147.1
0.87
19
72
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
94
621
1.52
3.72
1.2
1.2
u/ml
1.9
4.0
1.72
34
210
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
51
289
1.77
3.68
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
51
289
1.77
3.68
1.3
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
239
1859
1.30
3.66
5.5
5.3
%
0.9
0.9
0.09
224
1746
(3019225) pH of Specimen
513
4347
1.20
3.64
5.6
4.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
51
290
1.77
3.64
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
51
291
1.76
3.60
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
51
291
1.76
3.60
1.3
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
80
515
1.56
3.57
1.3
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
38
198
1.93
3.57
1.2
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
83
539
1.55
3.56
2.6
2.1
mg/l
26.3
22.7
0.31
30
133
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
51
292
1.75
3.56
1.3
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
48
270
1.78
3.56
1.1
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
388
3208
1.23
3.55
2.0
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
173
1291
1.35
3.55
3.7
3.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
143
1035
1.39
3.54
1.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
42
227
1.86
3.54
2.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
42
227
1.86
3.54
2.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
42
227
1.86
3.54
2.0
1.9
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
40
213
1.88
3.52
1.1
1.1
u/l
89.3
89.2
0.00
29
165
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
164
1215
1.36
3.52
3.3
2.7
%
215.7
193.7
1.79
155
1161
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
48
271
1.78
3.52
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
103
703
1.47
3.51
1.1
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
40
214
1.88
3.48
1.1
1.1
u/l
29.8
30.0
0.01
27
160
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
25
112
2.24
3.47
1.3
1.3
%
29.4
30.5
0.05
14
73
(3035880) pH of Pleural fluid
47
265
1.78
3.47
1.4
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1229
11174
1.13
3.43
5.2
4.1
%
87.9
87.9
0.04
1203
10923
(3014271) Vancomycin [Susceptibility]
41
223
1.85
3.40
3.7
2.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
21
88
2.39
3.38
2.0
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
642
5589
1.17
3.34
1.4
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
90
605
1.50
3.32
1.2
1.2
u/ml
3.4
4.8
0.97
44
257
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
17
65
2.62
3.30
1.2
2.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
57
345
1.66
3.29
2.1
1.9
umol/l
14.7
8.6
0.38
40
238
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
42
233
1.81
3.28
1.9
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
42
233
1.81
3.28
1.9
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
49
285
1.73
3.27
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
64
401
1.60
3.23
1.1
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
41
227
1.81
3.23
2.0
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
185
1422
1.31
3.14
1.9
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
32
165
1.95
3.13
1.1
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
17
67
2.54
3.12
2.0
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
563
4880
1.17
3.10
1.5
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
42
239
1.76
3.04
1.6
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
79
528
1.50
3.03
1.4
1.3
pmol/l
300.9
273.6
0.24
61
408
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
57
354
1.62
3.01
1.4
1.3
u/l
12.6
13.4
0.14
46
326
(3040151) Glucose [Moles/volume] in Capillary blood
77
513
1.51
3.00
5.3
19.2
mmol/l
8.2
7.4
0.77
64
432
(3012441) Differential panel - Pleural fluid
76
506
1.51
2.97
1.3
1.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
70
458
1.54
2.97
1.4
1.4
mmol/l
6.2
6.4
0.27
65
426
(3009214) Lutropin [Units/volume] in Serum or Plasma
148
1112
1.34
2.96
1.6
1.4
u/l
9.7
8.9
0.35
124
893
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
47
280
1.68
2.92
1.4
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
40
228
1.76
2.90
1.1
1.2
ratio
1.1
1.0
0.58
14
81
(3027315) Oxygen [Partial pressure] in Blood
140
1047
1.35
2.90
6.0
4.7
kpa
8.5
8.5
0.16
135
1030
(3010421) pH of Blood
159
1212
1.32
2.89
5.6
4.5
ph
7.4
7.4
0.53
133
1026
(3001019) Free T4 and TSH panel - Serum or Plasma
138
1829
0.75
2.89
1.5
1.7
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
14
52
2.70
2.88
1.6
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
126
928
1.37
2.88
1.5
1.4
e6/l
28.0
22.1
0.09
102
714
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
126
928
1.37
2.88
1.6
1.5
e6/l
1213.4
1264.2
0.02
108
755
(3013290) Carbon dioxide [Partial pressure] in Blood
139
1041
1.34
2.85
6.0
4.6
kpa
5.1
5.0
0.36
134
1025
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
32
171
1.88
2.85
2.2
2.2
ug/l
583.6
201.6
0.29
32
157
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
39
222
1.76
2.84
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
116
2.07
2.82
1.2
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
140
1052
1.34
2.82
1.1
1.1
u/ml
3.4
6.6
1.12
12
123
(3017704) Immunofixation for Urine
43
253
1.71
2.80
1.7
1.6
—
—
—
0
0
(3036489) Thrombin time
204
1618
1.27
2.77
2.5
2.3
s
21.5
21.7
0.16
184
1438
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
24
117
2.06
2.76
1.1
1.1
%
91.8
86.0
—
9
70
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
38
217
1.76
2.75
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
111
808
1.38
2.74
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
20
91
2.20
2.73
1.0
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
138
1041
1.33
2.72
6.0
4.6
mmol/l
2.5
2.6
0.10
100
712
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
141
1068
1.33
2.70
2.0
1.9
pmol/l
189.5
205.2
1.10
135
1007
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
36
204
1.77
2.68
2.3
2.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
99
711
1.40
2.66
1.1
1.1
iu/ml
82.7
847.0
0.50
23
164
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
24
119
2.02
2.65
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
469
4061
1.17
2.64
1.6
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
468
4057
1.17
2.60
2.9
2.5
u/l
32.7
51.2
0.92
408
3485
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
45
275
1.64
2.58
1.4
1.4
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
5
7
7.15
2.55
1.0
1.1
mg/l
1.4
1.2
—
5
7
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
44
2.73
2.54
2.4
1.5
umol/l
47.0
43.7
0.16
12
44
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
220
1784
1.24
2.50
2.1
2.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
23
115
2.00
2.50
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
55
356
1.55
2.50
1.5
1.5
—
—
—
0
0
(44806071)
12
45
2.67
2.45
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
13
51
2.55
2.44
1.1
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
37
219
1.69
2.40
2.1
2.4
mmol/l
8.9
9.3
0.26
27
170
(3003129) Base excess in Capillary blood by calculation
23
117
1.97
2.40
1.7
2.0
mmol/l
0.4
1.0
0.24
23
108
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
23
117
1.97
2.40
1.1
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
23
117
1.97
2.40
1.1
1.3
%
101.3
81.9
—
9
71
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
37
220
1.69
2.37
1.1
1.1
u/l
1.1
1.1
0.46
20
120
(3008536) Aspergillus sp Ab [Presence] in Serum
17
77
2.21
2.37
1.3
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
785
7101
1.12
2.36
3.6
3.0
e6/l
2.1
2.0
0.14
483
3895
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
26
140
1.86
2.31
2.8
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
26
140
1.86
2.31
2.8
2.4
—
—
—
0
0
(3019977) pH of Arterial blood
43
268
1.61
2.31
2.6
2.5
ph
7.4
7.4
0.16
13
96
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
184
1478
1.25
2.30
1.6
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
21
105
2.00
2.30
1.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
8
23
3.48
2.27
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
188
2315
0.81
2.26
1.4
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
24
127
1.89
2.25
1.5
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
24
127
1.89
2.25
2.4
2.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
23
120
1.92
2.25
1.1
1.1
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
23
120
1.92
2.25
1.4
1.4
%
30.3
22.6
0.52
16
98
(3024891) Influenza virus A+B Ag [Presence] in Specimen
139
1084
1.29
2.22
1.3
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
102
762
1.35
2.21
1.2
1.3
u/l
30.2
42.8
0.90
90
660
(3045414) Leukocytes [Presence] in Urine
235
1949
1.22
2.20
2.2
1.9
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
12
48
2.50
2.18
1.8
2.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
37
226
1.64
2.17
4.2
3.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
98
730
1.35
2.17
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
72
512
1.41
2.11
1.4
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
123
1.87
2.11
1.1
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
12
49
2.45
2.10
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
19
95
2.00
2.10
1.7
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
17
82
2.08
2.06
1.1
1.2
%
117.5
77.8
—
6
33
(3027456) Digoxin [Moles/volume] in Serum or Plasma
111
851
1.31
2.04
3.7
3.0
nmol/l
0.8
0.8
0.10
89
641
(3042951) Complement C1q Ab [Units/volume] in Serum
6
15
4.00
2.04
1.0
1.1
—
26.9
—
0
6
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
45
294
1.54
2.02
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
12
50
2.40
2.02
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
73
527
1.39
1.98
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
220
1834
1.21
1.98
2.2
2.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
78
570
1.37
1.97
2.3
2.3
pg
32.5
32.6
0.13
78
565
(3009015) Lactate [Moles/volume] in Synovial fluid
12
51
2.36
1.94
1.2
1.2
mmol/l
8.6
5.7
—
6
27
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
30
179
1.68
1.94
3.3
1.8
%
150.1
158.8
0.13
25
170
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
11
4.55
1.94
3.2
3.3
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
11
4.55
1.94
3.2
2.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
9
33
2.73
1.93
1.3
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
10
39
2.57
1.92
1.3
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
51
347
1.47
1.91
1.4
1.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
28
165
1.70
1.90
1.1
1.1
ng/l
161.1
341.2
—
10
45
(3044242) Glucose [Moles/volume] in Arterial blood
38
243
1.57
1.89
2.0
2.0
—
—
—
0
0
(4035726)
431
3812
1.14
1.89
1.5
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
33
204
1.62
1.88
1.5
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
33
204
1.62
1.88
1.5
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
65
2.16
1.87
10.6
12.0
mmol/l
5.7
6.2
0.13
14
65
(40761536) Microorganisms panel - Urine sediment
404
3560
1.15
1.87
5.5
3.9
—
—
—
0
0
(4306422)
81
602
1.35
1.86
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
403
3553
1.15
1.85
2.1
2.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
46
2.39
1.85
1.2
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
44
293
1.51
1.84
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
54
375
1.44
1.84
1.0
1.1
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
6
17
3.53
1.83
1.7
1.0
u/ml
11.1
0.8
—
6
12
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
39
253
1.55
1.83
1.5
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
64
459
1.40
1.83
1.4
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
115
1.83
1.82
1.1
1.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
283
2434
1.17
1.82
1.2
1.2
iu/ml
137.1
144.8
0.12
114
879
(4015189)
20
108
1.86
1.81
1.5
1.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
20
109
1.84
1.77
1.5
1.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
16
81
1.98
1.74
1.1
1.2
%
92.8
78.0
—
5
32
(3042517) Benzodiazepines panel - Urine
8
30
2.67
1.72
1.9
2.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
102
796
1.29
1.70
1.4
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
47
324
1.45
1.68
1.3
1.3
mmol/l
10.5
12.1
0.97
20
98
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
18
97
1.86
1.65
1.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
54
384
1.41
1.65
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
96
747
1.29
1.64
5.3
3.4
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
15
76
1.98
1.64
1.5
1.2
mmol/l
3.3
1.7
—
6
54
(3044290) Cell count panel - Cerebral spinal fluid
108
854
1.27
1.63
1.7
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
38
253
1.51
1.62
1.5
1.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
35
229
1.53
1.62
9.7
5.9
u/ml
45.0
800.6
—
9
49
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
34
221
1.54
1.61
1.4
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
40
270
1.49
1.60
1.9
1.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
63
463
1.37
1.60
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
148
1218
1.22
1.58
1.7
1.6
mu/l
276.6
297.7
0.39
139
1110
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
20
3.00
1.58
1.0
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
77
587
1.32
1.55
1.4
1.3
nmol/l
0.3
0.3
—
6
37
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
57
2.11
1.55
1.1
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
42
289
1.46
1.54
2.2
2.0
ug/l
4.2
3.5
0.19
34
250
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
75
570
1.32
1.54
1.1
1.1
%
120.1
114.1
0.90
70
518
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
166
1386
1.20
1.54
1.7
1.8
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
33
2.43
1.53
2.4
2.8
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
44
306
1.44
1.53
1.1
1.1
mg/l
281.3
301.7
0.30
39
260
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
15
3.34
1.52
1.0
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
36
242
1.49
1.49
1.3
1.3
nmol/l
1.3
1.2
0.26
29
188
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
75
574
1.31
1.48
1.1
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
21
124
1.70
1.46
1.4
1.9
u/l
15.8
56.9
1.35
21
117
(3004451) EKG impression Narrative
33
219
1.51
1.45
1.5
1.2
—
—
—
0
0
(4268621)
57
420
1.36
1.45
2.3
2.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
127
1040
1.23
1.45
1.3
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
59
2.04
1.43
1.1
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
29
188
1.55
1.42
1.2
1.5
%
50.6
65.8
1.13
22
155
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
36
245
1.47
1.42
1.5
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
24
149
1.61
1.40
3.5
2.8
umol/l
30.3
29.7
0.12
17
106
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
75
580
1.30
1.39
1.7
2.0
ug/l
15.4
25.2
3.29
75
572
(3052592) Norovirus Ag [Presence] in Stool
14
74
1.89
1.38
1.1
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
34
230
1.48
1.38
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
77
599
1.29
1.37
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
33
223
1.48
1.35
1.3
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
42
298
1.41
1.35
1.3
1.4
—
—
—
0
0
(4027681)
35
240
1.46
1.34
1.2
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
40
282
1.42
1.33
2.2
2.1
ug/l
2.2
2.1
0.06
34
240
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
60
453
1.33
1.33
1.6
1.4
nmol/l
0.2
0.3
0.97
47
345
(3036048) Francisella tularensis Ab [Titer] in Serum
18
105
1.72
1.33
1.2
1.2
—
184.0
—
0
5
(3020191) Ethanol [Moles/volume] in Serum or Plasma
49
360
1.36
1.29
2.0
1.3
promille
1.4
1.2
0.18
35
276
(3025549) Creatine [Moles/time] in 24 hour Urine
8
34
2.35
1.29
1.3
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
57
430
1.33
1.28
3.2
3.0
mg/l
83.3
43.8
0.43
45
329
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
114
938
1.22
1.27
1.9
1.8
iu/l
3.6
4.6
0.98
36
320
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
48
2.09
1.27
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
70
544
1.29
1.27
1.2
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
23
146
1.58
1.25
6.5
3.3
%
53.0
55.2
0.17
23
141
(3024928) Oxygen saturation in Venous blood
118
977
1.21
1.25
3.6
3.3
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
25
2.40
1.24
1.0
1.0
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
21
131
1.61
1.23
1.3
1.2
g/l
36.9
40.0
—
10
73
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
42
304
1.38
1.23
1.3
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
93
1.72
1.21
1.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
16
263
0.61
1.19
1.0
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
22
141
1.56
1.17
1.3
1.2
ug/l
53.6
372.8
0.95
14
72
(40768800) Prostate Pathology biopsy report
93
1135
0.82
1.16
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
43
316
1.36
1.16
1.2
1.2
mg/l
34.8
45.5
1.68
35
256
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
33
0.00
1.16
0.0
1.8
—
21.1
—
0
20
(3051611) Lipemic interference index of Serum or Plasma
57
438
1.30
1.15
3.8
3.3
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
20
2.50
1.15
15.0
10.8
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
18
110
1.64
1.15
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
18
110
1.64
1.15
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
18
110
1.64
1.15
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
18
110
1.64
1.15
1.1
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
313
2815
1.12
1.14
3.3
2.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
31
216
1.44
1.13
1.0
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
22
331
0.66
1.13
1.0
1.0
ng/l
784.7
724.8
0.34
15
224
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
17
103
1.65
1.12
1.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
30
2.34
1.12
1.4
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
16
96
1.67
1.10
1.1
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
12
66
1.82
1.08
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
12
66
1.82
1.08
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
12
66
1.82
1.08
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
68
540
1.26
1.08
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
41
304
1.35
1.06
2.4
2.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
57
445
1.28
1.04
1.8
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
33
237
1.39
1.04
2.0
2.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
22
2.27
1.03
1.0
1.2
—
—
—
0
0
(4212803)
9
46
1.96
1.03
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
54
420
1.29
1.02
1.3
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
23
155
1.49
1.00
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
57
448
1.28
1.00
3.1
3.6
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
9
48
1.88
1.00
1.6
1.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
23
333
0.69
0.99
1.0
1.0
ng/l
33.4
44.4
1.18
17
224
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
489
4536
1.09
0.98
3.4
4.2
ug/l
19.8
19.6
0.01
396
3738
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
23
332
0.69
0.98
1.0
1.0
ng/l
229.6
311.6
2.28
17
229
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
61
1.80
0.98
1.1
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
65
521
1.25
0.98
1.4
1.3
nmol/l
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
39
292
1.34
0.97
1.1
1.2
mmol/l
32.2
35.1
0.37
32
255
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
292
1.34
0.97
1.5
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
34
249
1.37
0.97
1.1
1.1
iu/ml
5.1
10.4
—
9
67
(3008116) Ketones [Moles/volume] in Urine by Test strip
15
92
1.63
0.97
2.7
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
50
1.80
0.96
1.6
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
19
124
1.53
0.96
3.3
1.6
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
77
1.69
0.95
3.6
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
51
1.77
0.94
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
11
62
1.78
0.94
1.3
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
16
101
1.59
0.93
1.1
1.5
ug/l
0.4
0.4
—
10
58
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
45
347
1.30
0.93
1.2
1.2
titre
226.7
153.2
—
9
66
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
28
2.14
0.91
1.0
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
564
5286
1.08
0.89
4.7
4.6
%
31.6
32.2
0.51
392
3580
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
8
42
1.91
0.88
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1204
11567
1.05
0.86
1.4
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
29
212
1.37
0.86
2.1
1.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
104
1.54
0.84
1.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
45
1.78
0.84
1.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
191
0.63
0.84
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
76
633
1.20
0.83
1.3
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
13
202
0.64
0.82
1.1
1.4
—
—
—
0
0
(4094501)
108
1251
0.86
0.82
1.1
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
35
266
1.32
0.82
3.6
3.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
65
1.69
0.82
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
87
736
1.19
0.81
1.5
1.5
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
24
0.00
0.79
0.0
1.0
—
94.3
—
0
15
(3025315) Body weight
6
33
1.82
0.79
5.8
3.9
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
0.2
—
0
10
(3014891) Appearance of Pleural fluid
11
66
1.67
0.78
1.7
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
18
123
1.47
0.77
1.2
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
29
217
1.34
0.76
2.1
1.6
u/field
1.1
3.2
1.41
21
154
(3013293) Extractable nuclear Ab [Presence] in Serum
10
59
1.70
0.75
1.9
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
67
559
1.20
0.74
1.2
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
24
2.08
0.74
1.0
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
54
1.67
0.74
1.2
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
20
141
1.42
0.74
1.1
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
117
1025
1.14
0.73
1.5
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
46
370
1.25
0.72
3.2
2.9
%
11.8
11.2
0.52
46
370
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
36
282
1.28
0.70
1.6
1.4
ug/l
2.4
4.4
1.26
29
244
(3023511) Choriogonadotropin [Units/volume] in Urine
57
472
1.21
0.70
1.3
1.3
—
—
—
0
0
(3001729) Color of Synovial fluid
7
41
1.71
0.70
2.7
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
21
152
1.38
0.69
2.1
1.9
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
13
85
1.53
0.68
3.7
3.1
u/l
85.7
83.4
—
6
30
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
107
941
1.14
0.65
4.5
3.4
mg/l
33.5
27.8
0.66
67
589
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
38
471
0.81
0.64
1.6
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
17
120
1.42
0.64
1.1
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
43
350
1.23
0.63
3.3
5.1
u/ml
238.9
62.3
—
9
99
(3048879) Bone marrow aspiration report
18
129
1.40
0.63
1.2
1.8
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
107
945
1.14
0.62
2.7
3.6
u/ml
436.5
802.5
0.40
96
867
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
8
53
1.51
0.58
1.1
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
32
255
1.26
0.58
1.2
1.1
nmol/l
15.5
7.0
—
7
55
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
55
1.46
0.56
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
90
0.56
0.55
8.4
7.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
66
763
0.86
0.55
1.3
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
38
461
0.82
0.55
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
38
459
0.83
0.53
1.5
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
39
1.54
0.53
2.5
2.4
u/field
0.5
0.7
—
6
39
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
82
723
1.14
0.52
1.8
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
75
1.47
0.50
1.6
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
67
584
1.15
0.50
3.3
3.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
46
390
1.18
0.49
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1021
10513
0.96
0.49
2.8
3.0
ug/l
0.7
0.8
0.33
677
7055
(3028717) Thiamine [Mass/volume] in Blood
7
46
1.52
0.48
1.1
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
13
93
1.40
0.48
1.1
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
93
1.40
0.48
2.0
1.8
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
12
85
1.41
0.46
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
45
384
1.17
0.45
2.0
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
76
675
1.13
0.45
1.5
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
7
50
1.40
0.45
1.7
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
50
1.40
0.45
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
110
1000
1.10
0.44
2.5
2.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
113
1030
1.10
0.43
2.5
2.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
14
104
1.35
0.43
1.9
2.9
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
31
1.61
0.43
1.2
1.2
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
8
56
1.43
0.42
2.6
1.5
nmol/l
0.2
0.1
—
8
37
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
57
1.40
0.42
1.5
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
48
552
0.87
0.41
2.9
2.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
42
360
1.17
0.41
1.3
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
4.8
—
3.5
—
0
10
(37019676) Renin [Units/volume] in Plasma --supine
0
16
0.00
0.41
0.0
1.1
—
11.1
—
0
9
(3001556) Androgen free Index in Serum or Plasma
5
34
1.47
0.40
1.2
1.2
—
—
—
0
0
(40758358) Immune stain study
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
88
1.36
0.40
1.6
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
13
97
1.34
0.39
1.5
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(4146454)
55
484
1.14
0.39
3.1
2.7
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
1.9
—
0
19
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
106
0.66
0.39
2.7
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
106
0.66
0.39
5.4
6.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
54
611
0.88
0.38
1.4
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
116
1.29
0.37
1.2
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
32
273
1.17
0.35
3.0
2.0
min
516.6
489.0
1.14
25
200
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
23
190
1.21
0.34
1.1
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
17
136
1.25
0.33
1.4
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
54
483
1.12
0.32
1.6
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
13
101
1.29
0.31
2.1
2.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
35
401
0.87
0.31
1.0
1.0
u/ml
2.3
0.4
—
8
109
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
177
1672
1.06
0.31
3.4
3.4
u/ml
119.3
65.7
0.30
170
1609
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
68
618
1.10
0.31
1.5
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
147
1382
1.07
0.30
1.5
1.4
iu/l
21.7
28.7
2.24
121
1153
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
15
120
1.25
0.30
2.4
6.6
%
72.8
71.7
—
10
97
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
130
0.77
0.29
1.6
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
147
1385
1.06
0.29
1.7
1.8
mg/l
3.8
3.9
0.06
114
975
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
76
1.32
0.28
1.3
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
64
1.25
0.27
1.8
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
48
433
1.11
0.26
1.0
1.1
u/ml
7.4
4.2
0.36
17
186
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
150
1.20
0.26
1.1
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
72
1.25
0.25
1.9
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
42
378
1.11
0.24
1.2
1.2
nmol/l
372.0
357.7
0.14
31
321
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
191
0.84
0.24
1.3
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
10
78
1.28
0.24
1.1
1.3
titre
—
95.5
—
0
13
(1761482) Bacteria [#/volume] in Urine by Culture
104
1105
0.94
0.23
4.8
4.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
52
568
0.91
0.23
2.8
2.3
mmol/l
4.1
4.1
0.20
52
559
(3035285) Chloride [Moles/volume] in Venous blood
52
568
0.91
0.23
2.8
2.3
mmol/l
105.0
105.6
0.37
52
559
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
57
524
1.09
0.23
1.1
1.1
u/ml
2.7
2.8
0.07
24
223
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
51
556
0.92
0.22
3.4
3.7
u/ml
34.5
32.8
0.04
51
539
(3039443) Prostate specific Ag panel - Serum or Plasma
96
1019
0.94
0.22
1.4
1.7
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
42
1.19
0.21
1.6
2.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006969) Lambda light chains [Mass/volume] in Urine
0
11
0.00
0.21
0.0
1.1
—
0.0
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
27
239
1.13
0.21
4.6
6.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
94
886
1.06
0.21
3.1
3.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
36
325
1.11
0.21
1.8
1.5
g/l
1.0
1.0
0.06
36
325
(4281824)
36
397
0.91
0.20
1.2
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
2.2
—
0
14
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
18
208
0.86
0.20
3.9
3.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
23
260
0.88
0.19
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
139
1330
1.05
0.19
2.3
2.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
16
137
1.17
0.18
1.3
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
18
156
1.15
0.18
1.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
138
1323
1.04
0.18
2.3
2.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
52
559
0.93
0.18
1.4
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
91
1.21
0.17
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
52
558
0.93
0.17
1.4
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
22
247
0.89
0.17
1.1
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
19
167
1.14
0.16
2.2
1.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
52
557
0.93
0.16
1.4
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
139
1336
1.04
0.16
2.3
2.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
16
139
1.15
0.16
1.8
2.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
18
204
0.88
0.16
1.2
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
52
556
0.93
0.16
1.4
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
71
1.13
0.16
1.4
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
63
596
1.06
0.14
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
135
1303
1.04
0.14
2.4
2.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
34
314
1.08
0.14
2.6
1.9
mmol/l
7.4
6.6
0.81
27
217
(3002523) Influenza virus A Ag [Presence] in Specimen
63
597
1.06
0.13
1.1
1.1
—
—
—
0
0
(44806420)
11
128
0.86
0.13
2.2
2.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
41
383
1.07
0.13
2.7
2.2
ml
683.0
624.4
0.34
30
248
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
33
356
0.93
0.13
1.4
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
180
0.89
0.13
4.5
2.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
13
113
1.15
0.13
1.6
1.5
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
19
171
1.11
0.12
1.7
2.3
e6/l
6012.2
4983.4
0.05
14
126
(3051593) INR in Capillary blood by Coagulation assay
19
210
0.90
0.12
21.6
11.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
163
1585
1.03
0.12
3.2
3.5
u/ml
1540.4
3586.8
0.43
136
1362
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
41
385
1.07
0.12
1.3
1.4
pmol/l
27.0
138.3
0.84
14
121
(3047189) Immunofixation for 24 hour Urine
24
220
1.09
0.11
3.2
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
32
299
1.07
0.10
2.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
127
1235
1.03
0.10
2.4
2.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
74
712
1.04
0.10
1.1
1.1
u/ml
4.0
2.2
0.40
34
305
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(4211845)
21
227
0.92
0.09
3.6
3.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
11
97
1.13
0.09
1.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
56
1.07
0.08
2.3
2.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
14
154
0.91
0.08
1.4
2.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
70
0.86
0.07
1.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
75
1.07
0.07
1.9
2.1
umol/l
11.8
16.7
—
8
75
(3051101) Glucose [Moles/volume] in Cord blood
8
76
1.05
0.07
1.9
6.7
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
8
78
1.03
0.07
1.3
1.1
pmol/l
—
6.3
—
0
10
(3041806) Other cells [#/volume] in Blood by Manual count
9
87
1.03
0.07
1.4
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
65
630
1.03
0.06
1.1
1.1
u/ml
6.3
5.0
0.28
37
338
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
173
0.92
0.06
1.9
3.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
217
2200
0.99
0.06
4.1
3.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
32
335
0.95
0.06
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
13
120
1.08
0.04
1.8
1.9
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
14
130
1.08
0.04
1.7
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
14
130
1.08
0.04
10.4
7.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
43
417
1.03
0.04
2.0
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
56
574
0.98
0.04
1.1
1.1
u/ml
1.5
2.1
0.29
13
142
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
51
523
0.97
0.04
1.4
1.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
18
189
0.95
0.03
1.3
1.0
u/ml
6.1
0.6
—
7
51
(40768795) Lymph node Pathology biopsy report
40
410
0.98
0.02
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
173
1719
1.01
0.01
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
342
3407
1.00
0.01
1.4
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
16
153
1.05
0.01
1.6
2.0
e6/l
8385.7
16141.5
—
7
87
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
54
532
1.02
0.01
1.1
1.3
mmol/l
7.2
7.4
0.13
37
393
(3014133) Dog dander IgE Ab [Units/volume] in Serum
48
473
1.01
0.01
1.0
1.1
u/ml
3.1
2.9
0.08
21
199
(3020874) Milk IgE Ab [Units/volume] in Serum
20
194
1.03
0.00
1.1
1.0
u/ml
44.4
0.8
0.46
12
66
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
33
336
0.98
0.00
2.2
2.0
u/field
1.3
1.9
0.45
13
128
(3008401) Mugwort IgE Ab [Units/volume] in Serum
61
616
0.99
0.00
1.1
1.1
u/ml
1.1
1.2
0.06
23
282
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
115
1.04
0.00
11.1
7.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
31
315
0.98
0.00
1.2
1.3
—
—
—
0
0
(4024509)
40
395
1.01
0.00
1.6
1.5
—
—
—
0
0
(4198724)
16
164
0.98
0.00
1.8
3.0
—
—
—
0
0
(4133840)
11
113
0.97
0.00
1.5
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
18
177
1.02
0.00
1.6
1.6
mmol/l
8.2
8.1
—
10
109
(3015183) Erythrocyte sedimentation rate
19
191
0.99
0.00
1.4
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
108
1079
1.00
0.00
1.4
1.6
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
1577.1
—
0
7
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
51
0.98
0.00
1.6
1.6
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
9
90
1.00
0.00
2.4
3.3
ml/dl
15.3
15.0
—
9
84
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
0.4
—
0
6
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
73
0.96
0.00
1.0
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_DERMATOPHYTOSIS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_DERMATOPHYTOSIS 1.662 [1.49, 1.85] < 0.001
Birth year 0.988 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 2070 out of 10637 females with AB1_DERMATOPHYTOSIS died.

Males

Parameter HR [95% CI] p-value
AB1_DERMATOPHYTOSIS 1.583 [1.43, 1.75] < 0.001
Birth year 0.986 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 3119 out of 13738 males with AB1_DERMATOPHYTOSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_DERMATOPHYTOSIS.

N-year risk Females Males
1 0.116% 0.267%
5 0.782% 1.751%
10 1.971% 4.39%
15 3.475% 8.116%
20 6.162% 13.442%

Relationships between endpoints

↥

Index endpoint: AB1_DERMATOPHYTOSIS – Dermatophytosis

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data